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ABSTRACT

Damayanti, Nur, P. Ph.D., Purdue University, August 2016. Linear and Nonlinear
Fluorescence Lifetime Imaging for Biosensing Applications. Major Professor: Joseph
Irudayaraj
Fluorescence techniques, based on both linear and non-linear excitation, have been widely
used in biosensing application. Among fluorescence techniques, Fluorescence Lifetime
Imaging (FLIM) has gained increased importance because of their robust and versatile feature.
FLIM is a technique to visualize the spatial distribution of picosecond to nanosecond excited
state lifetimes within microscopic images. In this work, FLIM technique combined with Time
Correlated Single Photon Counting (TCPSC) Technology was used to develop several novel
biosensing approaches. Using linear or nonlinear excitation source, TCSPC-FLIM enabled real
time monitoring of cellular metabolite profiles, as well as longitudinal observation of posttranslational enzyme activity such as kinase phosphorylation and acetyltransferase
acetylation. This technique will not only provide high spatiotemporal resolution of sensing
output but also for the first time, realize real-time biosensing in live intact single cell within 2
D culture, 3D culture and in-vivo animal model, zebrafish.
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CHAPTER 1. INTRODUCTION

1.1

Fluorescence Lifetime Imaging and Scope of Study

Fluorescence techniques, based on both linear and non-linear excitation,
have been widely used in biosensing application. Among fluorescence techniques used in
biosensing, in recent years’ Fluorescence Lifetime Imaging (FLIM) have gained increased
importance because of their robust and versatile character.
Fluorescence lifetime imaging microscopy (FLIM) is a technique to visualize the
spatial distribution of picosecond to nanosecond excited state lifetimes within
microscopic images. FLIM systems have been implemented both in the time domain,
using time gated or time correlated detection or in frequency domain employing
sinusoidal intensity-modulated excitation light and modulated detectors.
A spectroscopic approach based on FLIM for biosensing, can provide not only
information about the present of analyte but also its functional properties such as; its
environment, solvatochromic, redox state, pH, chemical modification, to name a few,
hence provides another dimension in fluorescence based biosensing.
In this dissertation linear and non-linear FLIM are used in different application
of biosensing. Linear and nonlinear term in this work correspond the nature of the
excitation source of FLIM which will be discussed in chapter 1.4.
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This dissertation is divided into seven chapters. All works are presented in the
manuscript format. Chapter 2 and 3 are published work and chapter 4 to 7 are prepared
manuscript for submission. Chapter 2 to 6 are the work of biosensor using linear FLIM
while the last chapter is non-linear FLIM. Chapter 2 describes FLIM biosensor utilizing
endogenous fluorophore for cancer detection and differentiation. Chapter 3 demonstrate
FLIM based biosensing for monitoring real time non-receptor kinase phosphorylation.
Chapter 4 describes FLIM based biosensor for monitoring FAK autophosphorylation.
Chapter 5 demonstrate the ability of FLIM based biosensor for multiplex kinase
phosphorylation detection. Chapter 6 reveals the ability of FLIM in monitoring real time
acetylation. The last chapter discuss non-linear FLIM using two photon laser to study the
effect of environmental toxicant in cellular metabolism.
1.1.1 Fluorescence Lifetime Imaging Advantages
FLIM technique offer several benefits compared to steady state fluorescence
techniques. One inherent character of FLIM is its low detection limit thereby necessitate
low excitation intensity. This feature is beneficial for live cell imaging because low laser
power will preserve cell viability. Another advantage of FLIM is that it is independent of
analyte concentration and it is inherently more robust toward photobleaching. These
character are suitable for longitudinal observations as oppose of end point measurement.
Fluorescence lifetime is also very suitable for live cell detection for the reason that
it has different property that can be easily separated from cellular or tissue auto
fluorescence. Tissue or cellular auto fluorescence commonly pose as major limitation in
fluorescence based detection1. However, cellular and tissue autofluorescence have
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distinct fluorescence lifetime value which can be easily resolved from the fluorescence
lifetime of designed reporter.
FLIM also offer high temporal resolution, due to the rapid nature of fluorescence
decay in picosecond to nanosecond range2. This feature allow evaluation of very fast
molecular or chemical process in material or biological specimen.
FLIM is independent of excitation source, wavelength and analyte concentration3,
. These feature will provide high spatial resolution, especially for analyte with very low
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concentration. Fluorescence lifetime signal can be obtain for single molecules5, 6 with
sufficient number of photon.
The fact that FLIM does not depend on excitation wavelength also give flexibility
in multiplex biosensing. Eventhough FRET biosensor has been implemented in many real
time biosensing application, spectral bleed through and limited FRET pair serve as
limitation in multiplex biosensing. In this case, FLIM offer solution for this problem. There
are many available reporters with the same wavelength but distinct fluorescence lifetime,
thereby providing broad possibility for multiplex detection by employing different
fluorescence reporter with different fluorescence lifetime.
1.1.2 Time Correlated Single Photon Counting
In principle, measuring florescence lifetime of reporter can be achieved by measuring the
how long the excited fluorescence molecule stays in the excited state. In practice, this
process is hard to achieve for several reasons. First of all, typical fluorescence reporter
decay in the range of picosecond to nanosecond7. Therefore, in order to record very fast
decay, and also to get the complete shape of decay, such as in the case of
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multiexponential decay, one must be able to temporally resolve the recorded signal by
some tens of samples. For instance, for a decay lasting, e.g., 500ps the signal would have
to be sampled at time steps of approximately 10ps. This required temporal resolution is
hard to achieve with ordinary electronic transient recorders. Moreover, the emitted light
may be too weak to generate an analog voltage representing the optical signal. Time
Correlated Single Photon Counting (TCSPC) circumvent this limitation.
Using TCSPC, the sample is scanned by the focused beam of a high-frequency pulsed laser.
Data recording is based on detecting single photons of the fluorescence light emitted and
determining the arrival times of the photons with respect to the laser pulses and the
positions of the laser beam in the moment of photon detection
In TCSPC8, the fluorescent molecules are excited with very short light pulses. In order to
achieve this pulse, usually picosecond or femtosecond excitation pulses are used. TCSPC
electronic is then record the time delay between excitation pulse and the time single
photon arrived in the detector. A trigger from the laser pulsed is synchronized with trigger
that start timing device such as Time to Amplitude Converter (TAC). The Photon from
excited fluorescence is detected with very sensitive detector such as photomultiplier or
avalanche diode. The output from the detector will stop the TAC. The signal from TAC is
proportional to the time between the start and stop pulse. The output of TAC will be then
digitized by Time to Digital Converter (TDC). From these output one can derive a photon
distribution over the spatial coordinates, x, y, and the times of the photons, t, after the
laser pulses. The result is a three-dimensional data array that represents the pixels of the
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two-dimensional scan, with each pixel containing photons in a large number of time
channels for consecutive times after the excitation pulse.
Usually, FLIM will consist of 512-2048 channels that will represent complete decay of the
sample. The recorded decay will be convoluted with the instrument response function of
the system (IRF).
One factor that should be taken into consideration in FLIM application is the
detector dead time. During dead time (125-350 ns), when photon arrived, it will not be
observed, which can result in shorter lifetime artifact. Therefore, it is important to
maintain low count rate during experiment to prevent photon pile up which will not be
observed.
Another way to prevent dead time, is the engineer of reverse TAC. In this case,
instead of starting the cycle by using laser pulse to trigger TAC, it uses detected photon
to start and laser pulse to stop. In this manner only useful event will be used.

1.1.3. Global analysis

To obtain accurate quantitative result from FLIM especially in FLIM-FRET
application, analysis method has to be chosen carefully. One of analysis technique that
will improve accuracy in data quantification is global analysis9. In this technique, data
from different experiment can be analyzed simultaneously. The assumption of this
technique is that some parameter will remain the same in different experiment. With this
method, fluorescence lifetime in all pixels will have similar value, but the intensity profile
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will be spatially different. Global analysis will consider all the decay in all location to
determine the kinetic of the decay.
With this analysis, each pixel will give information of decay, that is
fluorescence decay in each pixel can be considered as separate experiment. The data will
be stored as matrix, in this case each pixel can be described as I(t,x), in which I is the
intensity at time t at pixel x. Fluorescence lifetime across the pixel can be determined,
and also can be considered as the same, but the amplitude of the lifetime varied.
Even tough global analysis is computationally expensive, efficient computing
using this technique has been achieved by using bi-exponential kinetic model10. Several
other robust algorithm has also been successfully implemented in global analysis of
several FLIM data set or simulation10-12.
1.1.4 Graphical Analysis
Another technique beside global analysis is graphical analysis13,

14

. This

quantitative method was originally developed for frequency-domain FLIM. In graphical
analysis of FLIM data is translated into phasor or polar plot. This technique does not
require nonlinear fitting thus is more computationally efficient.
Graphical analysis as polar or phasor plot represent the mixture of each fluorescence
lifetime of fluorophore participant underlying complex lifetime distribution. The method
also works for FLIM data obtained with TCSPC even when low number of photon counts
is collected in 1 pixel of an image. Previous work transformed pixelated photon counting
histogram into phasor space. In the phasor plot, different fluorescence species will be
clustered in different region thus can be easily recognized. This method is also very
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powerful to identify two population of short and long lifetime in FLIM based FRET.
Because of its straightforward nature, graphical analysis of FLIM is suitable for
inexperienced user and also analysis of large dataset.
1.2 Fluorescence Lifetime Imaging as Biosensor
Fluorescence lifetime of fluorophore are sensitive toward its environment
and solvatochromic surrounding. This feature makes FLIM suitable for many applications
in bio sensing technology. One example of local environment sensing was done with using
FLIM to differentiate different organelle15, 16, cell type and organ17. Fluorescence lifetime
of ATP analog in myosin is different with the same analog in actin18. In other application,
conjugated Cy5.5 to antibody rituximab demonstrate higher fluorescence lifetime in the
inner layer of tumor compared to its surrounding tissue19.
FLIM has also been applied to measure concentration of analytes, such as
glucose in which fluorescence lifetime of glucose sensor increase with the rise of glucose
concentration20. Another example for analyte detection with FLIM is the measurement of
Cl- ion concentration21,

, by using Cl sensitive dye

22

N-(Ethoxycarbonylmethyl)-6-

methoxyquinolinium bromide (MQAE). The fluorescence lifetime of the dye will decrease
with the presence of Cl ion.
Fluorescein, has also been used in FLIM based biosensing for its sensitivity toward its
environmental pH. Fluorescein lifetime changes from 3.78 ns to 4.11 in the relevant pH
range (pH 6-8)23. Another more sensitive dye, BCECF has been shown to have better
dynamic range as pH indicator with lifetime change from 2.75 ns to 3.9 ns in pH range
4.5 to 824. FLIM has also been implemented in detecting cellular Ca2+ by using Oregon
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Green BAPTA-1, calcium green-1 and magnesium green25, 26. Another intracellular ion
that can cause shift in fluorescence lifetime of sensitive dye is Zn2+.
1.3 Fluorescence Lifetime Imaging of Endogenous Fluorophore
Biological tissue and cell contain variety of endogenous fluorophore. The
fluorescence lifetime of most of them depend metabolic state of the tissue, oxygen
concentration, presence of binding protein and other biologically relevant parameter.
Therefore, the decay functions of autofluorescence will provide complex biological
information about cells and tissue. The presence of multiple endogenous fluorophore in
cells and tissue will require multiexponential model to resolve fluorescence decay.
In this case, TCSPC-FLIM will be suitable technique to extract biologically relevant
information of endogenous fluorophore for several reasons. First, TCSPC=FLIM will record
fluorescence decay at high time resolution and sufficient number of channel that will
allow multiexponential decay analysis.
One prominent example of the use of FLIM to study endogenous biomarker is the
study of NADH and FAD. These electrons transfer related metabolite show different
profile of fluorescence lifetime in different state of cell or tissue metabolism. Moreover,
the two metabolites also form redox pair, and their bound unbound status can be
differentiated by their fluorescence lifetime. The application for FAD /NADH fluorescence
lifetime measurement have been implemented in cancer cells differentiation27, cell
maturation in apoptosis28 and tumor drug response29.
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1.4 Linear and Non-Linear Excitation for Fluorescence Lifetime Imaging
In the domain of linear optics, the response of the induced polarization to the
incident electromagnetic field is linear with the amplitude of the field. Linear optical in
fluorescence lifetime application can also be explained as fluorescence lifetime imaging
with linear excitation source. In this case, linear excitation source is defined by its linear
feature between the emitted signal and the adsorbed flux of photon. In the other word,
the fluorescence emission is linearly proportional to the excitation intensity. This
relationship can be represented in equation 1.
F = σ × Q × I………………………………………………………. (1)
In which F is the fluorescence emission and I is the incident light flux, Q is the quantum
yield and σ is absorption cross section. One photon laser excitation is one example of
linear optic. Therefore, In the FLIM application, using one-photon pulse laser as excitation
source can be categorized as linear FLIM.
Nonlinear system is a system in which the output is not directly proportional to
the input. In Fluorescence lifetime imaging, non-linear system is defined by non-linear
excitation source of FLIM. One example of non-liner excitation is two-photon laser. In
two photon excitation source, the emission is no longer linearly proportional to the
excitation intensity. Instead, the absorption increase quadratically with the excitation
intensity. The theory of two photon excitation was first described by Goeppert-Mayer.
The use of two-photon laser excitation in fluorescence imaging offer severeal advantages.
First, because the absorption process increase quadratically with the excitation intensity,
the fluorescence confined to the vicinity of focal point. This will provide better three
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dimensional resolution compared to FLIM obtained with linear excitation. This feature
will be useful for deep tissue or whole in-vivo imaging. Second, longer wavelength in NIR
region can be used to excite UV region fluorophore, which can limit photodamage and
phototoxicity for live cell imaging. In summary, the near IR, efficient detection of
fluorescence photon will enable deep imaging in turbid media with low concentration of
fluorophore.
1.5

Kinase Phosphorylation Biosensor

Kinase phosphorylation is the major post-translational modification that
govern various cellular responses. Considering its pertinent roles, there are several
questions need to be addressed in monitoring kinase activity. One of the most important
question in kinase activity is when a specific protein kinase active. To address this
temporal question, most common method is by exposing population of cell to stimulus,
lysate it, purifying kinase target by immunoprecipitation, and then assay its activity by
using method such as phosphorylated site detection of its specific site. This common
method has limitation in which kinase activity is sampled in non-continuous fashion and
outside its native environment. As results, the requisite endogenous component (proteins,
allosteric effectors), environmental conditions (transient pH or metal ion gradients), and
intracellular milieu that can modulate the activity of the protein kinase under study may
be absent.
Several traditional methods to detect kinase activity employing cell lysate have
been documented. One common method is using ELISA technique. Figure 1.1
demonstrate the working principle of the assay.

11

Figure 1.1 ELISA-based detection of kinase activity using peptide biosensor
Briefly, cell is exposed to peptide sensor that will target specific kinase. After cell
stimulation, cell was lysed and cell lysate containing phosphorylated peptide substrate of
kinase target placed in Neutravidin™ coated well. Phosphorylated substrates are labeled
with the anti-phosphotyrosine antibody, 4G10. The primary antibody is labeled with a
horseradish peroxidase-conjugated secondary antibody. Finally, Amplex Red™ is added to
the well and oxidized to a fluorescent reporter in the presence of horseradish peroxidase.
Another common technique for detection of kinase activity using peptide
substrate are western blot and radioactive labeling, However, radioactive labeling is
unattractive method due to its potential waste safety hazard.
Another method to detect kinase activity using peptide substrate is by using mass
spectrophotometry. Peptide phosphorylation can be detected by mass shift of 80 Da. This
method is powerful for its enable multiplex detection of numbers of peptide in one assay.
Therefore, this technique provides robust platform for high throughput screening.
Moreover, mass spectrophotometry only requires small amount of cell lysate which
makes this technique very sensitive. However, as any other lysate based method, the
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absence of native cellular environment of kinase, may compromise the biological
information that is obtained through this technique.
1.6 Acetylation Biosensor
Acetylation is another post translational modification that recently
garnered attention its pivotal roles in key physiological processes such as metabolism,
circadian rhythm and cell cycle, along with gene regulation in various organisms30.
Dysregulation of acetylation has been implicated in many diseases such as metabolic
disorder31, neurological disorder32, 33, and cancer34.
Considering its importance in maintaining physiological homeostasis in different
organism, several techniques have been developed to detect and quantify acetylation
process. Time resolved luminenscence with peptide biosensor has been used to detect
Histone Acetyl Transferase (HAT) activity as well as Histone Deacetylase (HDAC)
activity35 .This method utilize the ability of acetylation to change peptide surface charge
thus modulate DNA/peptide binding interaction which result in recovery of luminescence
signal.
Another method of acetylation detection was by using genetically encoded H4
region including bromodomain and link to Venus and CYP reporter 36, 37. Upon acetylation
the distance between two reporter decrease and change the Forster Resonance Energy
Transfer signal.
Electrochemical based sensor was also developed to detect acetylation38
employing acetylated peptide substrate and antibody that will decrease electrochemical
sensor in the presence of histone deacetylase enzyme.
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CHAPTER 2. HYBRID FLIM-ELASTIC NET PLATFORM FOR LABEL FREE PROFILING OF
BREAST CANCER

2.1 Abstract
We report a label-free fluorescence lifetime profiling strategy to classify breast cancer
cells, MCF10CA1h (malignant), MCF10A (nonmalignant), and MCF10AneoT (premalignant)
in different stages of malignancy. Fluorescence Lifetime Imaging Microscopy (FLIM) was
used to record the lifetime of autofluorescence of endogenous flavin in MCF10 cells in
different stages of malignancy. Predominant differences in lifetimes ascertained by multiexponential fitting curves can be attributed to the different forms of flavin protein; flavin
mononucleotide (FMN), free flavin adenine dinucleotide (FAD), semiquinone, and bound
FAD. A lifetime map of the metabolite was derived from the contribution of the lifetime
of each metabolite by iterative reconvolution fitting of the Time Correlated Single Photon
Counting (TCSPC) decay curves. Lifetime maps were constructed by mapping the average
lifetime values pixel by pixel using MATLAB. The FLIM image (150 × 150 pixels) of each cell
was extracted, resized and centered into 100 × 100 pixels using the nearest neighbor
algorithm. Principal Component Analysis (PCA) in conjunction with Elastic net Analysis
(EnA) was then used to classify the different stages of MCF10 cell lines based on average
lifetime values. The EnA model provided an excellent classification of the cells at different
stages of tumorigenesis yielding 100% accuracy.
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2.2 Introduction
Radiological methods such as mammography are effective in identifying
suspicious lesions. However, a significant number of false positives are identified.1 A
follow-up diagnostic procedure such as percutaneous core-needle image guided biopsy is
often necessary to reinforce the evaluation. In core needle biopsy, samples from the
tumor are evaluated, however, only a small section of the tissue is extracted from the
region of interest.2 It is known that fluorescence imaging offers high resolution and high
sensitivity to detect early malignancy in human organ sites, including the gastrointestinal
tract, skin, bladder, esophagus, and colon.3–7 Fluorescence spectroscopy-based image
guided core needle biopsy may have excellent potential to reduce false negatives. The
second potential application of fluorescence imaging is in the assessment of tumor
margins during surgery.3 Accurate real time imaging will enable lesion localization that
otherwise is challenging by visual observation or palpation. 1Fluorescence techniques rely
on suitable biomarkers that are targeted by fluorescent labeled ligands.8,9
Fluorescence spectroscopy can also benefit from information that can be derived
from innate structures or endogenous fluorescence of biological tissues, such as aromatic
amino acids (tryptophan, tyrosine, and phenylalanine),10 structural proteins (collagen and
elastin), lipopigments (e.g., ceroids and lipofuscin)11 metabolites–enzymes, and
coenzymes such as flavin mononucleotide (FMN),12–14 nicotinamide adenine dinucleotide
(phosphate) (NAD(P)H),15,16 and flavin adenine dinucleotide (FAD).17,18 The innate
fluorescence characteristics of these analytes can be used to study the underlying
mechanisms under physiological conditions.
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Fluorescence Lifetime Imaging Microscopy (FLIM) is a robust technique19 with
several key advantages: (i) the lifetime of a fluorophore is independent of fluorophore
concentration, photobleaching, initial perturbation conditions, excitation wavelength,
light exposure conditions, method of measurement, and laser power, (ii) fluorescence
lifetime can be sensitive to a variety of internal factors defined by the structure of the
fluorophore and external factors that include temperature, polarity, and the presence of
fluorescence quenchers,20 and (iii) distinct fluorescence lifetime in the same pixel
originating from fluorophores that are excited at the same excitation wavelength can be
resolved with appropriate fitting functions.21,22 These characteristics render FLIM as an
attractive tool to report on localization, microenvironment, and binding kinetics23 in a
label free manner or using simple reporters. Real-time spatiotemporal alterations of
metabolites with innate fluorescence might have the ability to provide information on the
biochemical/physiological changes within a cell.24
Flavin molecules are one of the most important fluorescing metabolites beside
NADH.17 They play an important role as a cofactor in enzymatic functions.18 Flavin
mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are the most commonly
occurring flavins in flavoproteins, which comprise a fluorescent heterocyclic isoalloxazine
ring with ribityl phosphate and ribityl adenine diphosphate (Fig. 1). Flavins can have
different redox states,25 including: the oxidized form of FAD+ (referred to as FAD from
here on), one-electron reduced radical semiquinone (FADH˙) and the fully reduced two
electron state (FADH2). Because of the same chromophore, isoalloxazine, FAD, FMN and
semiquinone, the radical forms of FMN,24 share the same excitation (450–480 nm) and
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emission (520–550 nm) wavelength.26 This can be a potential drawback for fluorescence
intensity-based measurements, because it will be difficult to identify the presence of
different flavins in the same region of interest. Separate studies however, show that the
three molecules have distinct lifetimes, FAD (2.3–3 ns),27 FMN (4.2–4.7 ns),28 and
semiquinone (0.7–0.8 ns).29 Previous studies show a dramatic decrease in the lifetime of
FAD which is identified as the bound FAD to the order of 0.01–0.1 ns.29 A lifetime
fingerprint of each flavin compound is not only an excellent alternative to intensity-based
imaging but could also serve as a powerful label-free screening tool.

Fig. 2.1 Isoalloxazine is a chromophore of both Flavin Mononucleotide (FMN) and
Flavin Adenine Dinucleotide (FAD).
The redox state of flavin promotes its versatile nature that cause its ubiquitous
presence and plays a key role in a wide range of biological processes in a cell, such as,
redox reaction, ATP synthesis, light driven DNA repair, electron transport chain,
detoxification, cell apoptosis, halogenations of aromatic substrates, mitochondrial
activity, cell apoptosis, oxygen activation and dehydrogenation of metabolites.30
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Breast cancer gives rise to diverse phenotypes, molecular signaling and a complex
microenvironment. Its heterogeneity poses a formidable challenge in cancer diagnosis
and prognosis. While conventional breast cancer staging relies mainly on histology and
immunopathology,31 more recent techniques involve monitoring of key biomarkers by
biomolecular approaches.32,33
The role of flavin in a broad spectrum of biological activities makes it a potential
biomarker for breast cancer screening. In this work we will use FLIM to monitor the
lifetime of flavin for breast cancer classification (Fig. 2) using live cells. Autofluorescence
of endogenous biomarkers such as NADH and FAD has been used to evaluate frozen
breast cancer tissues.33However, frozen samples may not be the best indicators of the
fluorescence state as they give rise to false negatives and false positives34 especially if the
metabolite is in a dynamic metabolic state. For relevant information such studies need to
be carried out under physiological conditions in live cells. Fig. 2 demonstrates the
schematic for label-free classification using the lifetime of autofluorescing flavin
compounds. Our approach combines FLIM, PCA and Elastic net Analysis (EnA) for
metabolite profiling for breast cancer classification based on whole single cell analysis.
Pixel by pixel analysis of FLIM was conducted to differentiate the metabolite source in
each pixel from the lifetime. PCA and EnA were then used to analyze the complex data.
Few learning dimensionality reduction algorithms (Lasso35 and Elastic net36) were
developed not only to achieve a reduction in dimension but also to reduce the number of
explicit variables used. Sparse data are more succinct and simpler, so that explicit and
relevant models can be developed. They also provide control over the weights of original
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variables that have the potential to decrease the variance brought about by possible overfitting with the least bias. Elastic net Analysis (EnA) is a version of penalized least squares
that combines both Ridge and Lasso regression. Ridge regression shrinks (toward zero)
the least square coefficients while Lasso regression, both, shrinks the coefficients and
assists in model selection. Unlike Lasso penalty, the Ridge penalty (L2-penalty), drawn
from a Gaussian distribution, is ideal if there are many predictors and all have non-zero
coefficients. In elastic net the penalty is a compromise between the Ridge-regression
penalty (α = 0) and the Lasso penalty (α = 1).36

Figure. 2.2 FLIM autofluorescence to classify MCF10 breast cancer cell lines based on a
metabolite profile.
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Due to the advantages and the importance of data reduction, Lasso and Elastic net
are frequently used in domains with very large datasets, such as genomics and web
analysis.37However, few studies have demonstrated the potential of EnA in spectral
analysis.36–38 Considering the large number of variables or pixels in each of the images
obtained in the present study, EnA was used as a possible method for variable selection
and classification of cell lines that represent the different stages of breast cancer.
2.3 Materials and Methods
Cell lines
MCF10 series were derived from benign breast tissue from a woman with fibrocystic
disease.39 The MCF10 series consists of MCF10A (non-malignant), MCF10AneoT
(premalignant), and MCF10CA1h (malignant) cell lines. MCF10AneoT (premalignant) was
derived from MCF10A by introducing the T24-Ha ras oncogene,39 which after a series of
transplantations in immune compromised mice, gives rise to the MCFCA101h (malignant)
cells. The MCF10 cell lines are isogenic and represent the major stages in breast cancer
progression and hence were used as a model in our study. The cells lines were obtained
from Professor Julia Krishner's laboratory (Purdue University). The cells were first cultured
in a 25 cm2 flask (Thermo Scientific Nunc) for 4 days to 80% confluency, trypsinated, and
plated on a 18 mm cover slip in 12 well plates. For imaging, cells were cultured until 60–
70% confluence is reached before imaging.
FLIM instrument and measurement setting
Fluorescence lifetime can be defined as the time in which the fluorescence intensity is
decreased to 1/e of its initial intensity.40 Fluorescence lifetime was measured using the
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Microtime 200 (Picoquant, GmbH, Berlin, Germany) fitted with a picosecond pulsing (40
MHz) diode laser at 467 nm excitation with a laser power of ∼4 μW. The laser was focused

on the sample using an apochromatic 60× water immersion objective with 1.2 NA. Off-

focus fluorescence was rejected by the 50 μm pinhole. Emitted fluorescence was
collected using the same objective and separated from the excitation beam using a
dichroic mirror. A band pass filter (480–520) was used to ensure that the collected
photons are from the autofluorescence of the flavin-type molecules and not due to NADH
autofluorescence. Fluorescence emission was collected using the single photon avalanche
photodiodes (SPAD, SPCM-AQR-14, Perkin-Elmer). Each photon was tagged with a time
stamp that signifies its arrival time in the detector after a laser pulse, using the time
correlated single photon counting (TCSPC) in the Time Tagged Time Resolved Single
Photon Mode (TTTR) (Timeharp 200, Picoquant). Details of instrumentation can be found
in our previous work.40,41
FLIM fitting
Iterative

reconvolution

fitting

was

accomplished

with

the

Levenberg–

Marquardt42 routine for non-linear least square fitting using the fluorescence decay
curves collected for each pixel in the 150 × 150 pixel image to a model multi-exponential
decay function of the form:

………………….. (1)
where I(t) is the fluorescence intensity at time t after the excitation pulse, n is the total
number of decay components in the exponential sum, and c is a constant pertaining to
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the level of background light noise. The variables τi and αi are the fluorescence lifetime
and fractional contribution of the ith emitting species, respectively. Iterative
reconvolution fitting was performed to take into account the Instrument Response
Function (IRF). Assessment of fitting was done by minimizing the Chi-square value
generated during fitting. Goodness of fit was determined by excluding a Chi square
value greater than 1.3 to ensure unbiased fitting. The average lifetime values in each
pixel were exported to MATLAB for further analysis.
FLIM image processing for intensity, lifetime, and metabolite mapping
Pixel by pixel average intensity and lifetime values were separated using MATLAB. The
intensity and lifetime maps were visualized using ImageJ in 2.5 D. The intensity fraction
for each lifetime value was calculated for the 150 × 150 pixels based on the results from
multi-exponential fitting. The value of the intensity fraction corresponding to each
metabolite was then mapped to create a metabolite image. All mapping and image
processing techniques were carried out by Symphotime (Picoquant), MATLAB and
ImageJ. One way ANOVA and a Tukey multiple comparison post test were done to
compare the mean lifetime.
FLIM image processing for classification
Each cell was boxed, centered, and resized to a 100 × 100 pixel area using the nearest
cell algorithm in MATLAB. Each pixel for all 72 cells was further analyzed and classified
using PCA and EnA.
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PCA
Principal Component Analysis (PCA) was performed using MATLAB with the PLS_Toolbox
(Eigenvector Research, Inc.). Mean centering calculation was previously applied to the
raw data matrix. The plot of the Hotelling T2 statistics versus the Q residual
contributions was used to identify samples that had a Q statistic greater than the 95%
confidence limit, which could be indicative of the sample exhibiting unusual variance
that was not captured by the model.43 Only one image from the normal cell was
identified as outlier and excluded from further analysis.
Elastic net Analysis
Elastic net Analysis was performed using the glmnet package with the R software.
Samples were randomly separated into training (75%) and validation (25%) sets. In order
to obtain the value of the regularization parameter lambda that gives minimum crossvalidated error, a 10-fold cross-validation was performed using the glmnet.cv function.
Sequentially, generalized linear models for the training data set were fitted, using the
glmnet function, at α-values ranging from 0 to 1, in steps of 0.25. The predict.glmnet
function was used to classify observations from the calibration and new observations
from the validation data set. The α-value that provided a higher predictability based on
the lowest classification error was considered. The coef.glmnet function was finally used
to print the discriminant pixels used in the developed model and their respective
coefficient estimates
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2.4 Results and Discussion
Intensity images (Fig. 3d–f) show elevated intensity in the mitochondria region for
malignant cells (3d), compared to normal (3e) and transformed cells (3f). The elevated
intensity in the mitochondria area in malignant and transformed cells compared to
normal, could be an indicator of increasing mitochondria related activity with cancer
progression. However, it is very difficult to distinguish the fluorescing compound based
on just intensity differences (at 460 nm excitation). Pixel by pixel multiexponential decay
fitting of FLIM images shows consistent values for the lifetime of the four different groups
of cells as follows: 10–50 ps, 0.5–0.7 ns, 1.8–2.5 ns, and 4–4.7 ns. Previous studies on the
lifetime of endogenous metabolite had values of 1.8–2.5 ns for FAD,33 4–4.7 for
FMN,28 and 0.5–0.7 ns for semiquinone12 and in the picosecond range for protein bound
FAD.10 Pixel by pixel quantitative analysis of a minimum of 20 cells shows different
average lifetimes for each metabolite in different breast cancer cells at different stages
of tumorigenesis (Fig. 3). Fig. 3 shows that the lifetime of FMN and FAD decreases with
an increase in malignancy, while FAD bound lifetime increases with cancer progression. A
significant change in the lifetime of semiquinone with cancer progression was not
observed.
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Figure. 2.3 Cancerous cells show increasing intensity around the mitochondria area
compared to the normal and transformed cells. Elevated intensity in the mitochondria
area was observed in the following order: (a and b) MCF10CA1h > (c and d) MCF10AneoT
> (e and f) MCF10A. Metabolites show different lifetimes in cell lines that represent
different stages of breast cancer. FLIM map of mitochondria related metabolites: FMN,
FAD, FAD bound and semiquinone, in (a and b) MCF10CA1h, (b and c) MCF10AneoT, and
(d and e) MCF10A. Significant differences (P < 0.05) exist within MCF10CA1h,
MCF10AneoT and MCF10A for FMN, FAD and FAD bound lifetime. No significant
difference (P > 0.05) was observed for semiquinone.
Fig. 4(a–m) show the map of the contribution of each metabolite based on its
lifetime coefficient from TCSPC fitting. A significant (P < 0.05) difference in FMN and
protein bound FAD in MCF10 cell lines was noted. Contrary to its lifetime, the contribution
of FMN increased with malignancy, while the contribution of bound FAD decreased with
malignancy (Fig. 4c, g, k, m and n and 5). No significant change in the lifetime of FAD and
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semiquinone was noted between normal and transformed cells, while a significant
increase in the contribution of FAD from malignant cells was noted.

Figure. 2.4 Metabolite map in different stages of cancer cells. Metabolite mapping based
on lifetime contribution of each metabolite: (a, e and i) semiquinone, (b, f and j) FMN, (c,
g and k) FAD, (d, h and i) protein bound FAD. Pixel by pixel quantitative analysis for each
lifetime contribution (m), averaged for each 150 × 150 pixel for n = 20 cells. Significant
difference (P< 0.05) was observed for bound FAD and FMN for each stage of MCF10 cell
lines. There is no significant difference in FAD and semiquinone for normal (MCF10A) and
transformed (MCF10AneoT) (P > 0.05) cells, however, there is a significant difference (P <
0.05) between normal and malignant cells. (n) Representative lifetime and its
contribution histogram for each stage of the MCF10 cell line.
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Figure. 2.5 A decrease in the FAD bound contribution in MCF10 cell lines was noted in the
following order: MCF10A > MCFCAneoT > MCF10CA1h. A 2.5 D image of an FAD bound
contribution profile in different stages of MCF10 cell lines: (a) MCF10A, (b) MCF10AneoT,
and (c) MCF10CA1h. The z-axis denotes the fraction contribution (0–100%) of lifetime in
the corresponding pixel.
Our results show a significant difference in the autofluorescence lifetime of flavin
in different stages of MCF10 cell lines, providing proof that fluorescence lifetime imaging
can be used as a new method for label-free classification. With further modifications we
expect our methods to be applied in image guided percutaneous core needle biopsy or
image guided surgery. However, image based classification can be visually challenging,
especially when we apply this method to a complex structure such as tissue. Therefore,
the use of a suitable analysis method is appropriate for the classification of lifetime
images into different classes based on tumorigenesis. PCA and EnA will be applied for
lifetime data processing for breast cancer classification.
For the PCA models constructed for MCF10a, MCF10neoT, and MCF10CA1h (Fig.
6a), the first two PCs separated the normal (MCF10a), transformed (MCFneoT), and
malignant cells (MCFCA1h). Normal and malignant cells were clearly separated, and they
indicate a significant difference in lifetime between the groups. This result is in
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accordance with our quantitative analysis which shows a significant difference (P < 0.05)
in the lifetime of FAD, FMN, and bound FAD in normal and malignant cells. Transformed
cells are classified in between normal and malignant but some of the cells belong to the
normal and some to the cancerous stage. This finding is supported with our quantitative
results which show no significant difference in lifetime and contribution of FAD,
semiquinone, and FMN in normal and transformed cells.
Besides being a robust variable selection method, EnA was chosen as the method
for statistical classification because it provides a good interpretation of a model, revealing
an explicit relationship between the objectives of the model and the given variables. After
the removal of outliers, a variable selection process using EnA was performed. Fig. 6h–
j show a comparison of the number of variables used in the model by EnA (Fig. 6 i), Ridge
(Fig. 6h), and Lasso (Fig. 6j). Fig. 6a–g show a 3D visualization of the coefficients of the
estimate for α = 0.5. Positive peaks show that higher lifetime values contribute towards
correct classification and negative peaks indicate that lower lifetime values contribute
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Figure.2.6 MCF10 breast cancer cell lines were correctly classified based on
metabolite lifetime values using EnA. (a) PCA analysis. PC1 is responsible for 14.6% within
samples, and PC2 is responsible for 6.7% of the variation in the sample. (b–g) Elastic net
coefficient estimates for α = 0.5. A peak indicates that the correct classification of lifetime
is associated with the corresponding pixel region. A positive peak indicates higher lifetime
than other classes; a negative peak indicates lower lifetime. (b and e) MCF10A, (c and f)
MCF10AneoT and (d and g) MCF10CA1h. Variable selection for the model (g–i). Different
approaches were chosen to select variables that need to be included in the model (h)
Ridge approach, (i) elastic net, and (j) Lasso.
towards the correct classification. In normal cells, the correct classification was
mostly due to lower lifetime values compared to other groups (Fig. 5b and e) and only a
minor contribution was noted from higher lifetimes compared to other classes. For cancer
cells (MCF10CA1h) (Fig. 5d and g), the correct classification was observed predominantly
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from higher lifetimes, unlike in normal and cancer cells, both negative and positive
coefficients were noted in pre-malignant cells.
Besides being a robust variable selection method, EnA was chosen as the method
for statistical classification because it provides a good interpretation of a model, revealing
an explicit relationship between the objectives of the model and the given variables. After
the removal of outliers, a variable selection process using EnA was performed. Fig. 6h–
j show a comparison of the number of variables used in the model by EnA (Fig. 6 i), Ridge
(Fig. 6h), and Lasso (Fig. 6j). Fig. 6a–g show a 3D visualization of the coefficients of the
estimate for α = 0.5. Positive peaks show that higher lifetime values contribute towards
correct classification and negative peaks indicate that lower lifetime values contribute
towards the correct classification. In normal cells, the correct classification was mostly
due to lower lifetime values compared to other groups (Fig. 5b and e) and only a minor
contribution was noted from higher lifetimes compared to other classes. For cancer cells
(MCF10CA1h) (Fig. 5d and g), the correct classification was observed predominantly from
higher lifetimes, unlike in normal and cancer cells, both negative and positive coefficients
were noted in pre-malignant cells.
Table 1 summarizes the results obtained by the generalized multinomial logistic
model constructed via the penalized maximum likelihood method. The respective model
was constructed for a value of α = 0.5 that minimized the classification error. Excellent
predictions were obtained for the classification of cancer cells and satisfactory results for
the classification of normal cells. Transformed cells exhibited low sensitivity. Sensitivity
analysis from the validation set indicates that 50% of the transformed cells can be
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classified as either cancerous or normal. On the other hand, sensitivity results from cancer
cells revealed that 100% of cancer cells could be correctly classified in all sample sets.
Table 1 Sensitivity, specificity, and classification error from Elastic net Analysis

Table 1 summarizes the results obtained by the generalized multinomial logistic model
constructed via the penalized maximum likelihood method. The respective model was
constructed for a value of α = 0.5 that minimized the classification error. Excellent
predictions were obtained for the classification of cancer cells and satisfactory results for
the classification of normal cells. Transformed cells exhibited low sensitivity. Sensitivity
analysis from the validation set indicates that 50% of the transformed cells can be
classified as either cancerous or normal. On the other hand, sensitivity results from cancer
cells revealed that 100% of cancer cells could be correctly classified in all sample sets.
The results presented validate our study on classification strategies using the
lifetime of autofluorescence to current histopathology assessment in breast cancer
diagnosis. The combination of FLIM with EnA presents a robust approach to breast cancer
classification with a specificity of 93% for cancer, 88% for normal, and 87% for premalignant cells. The use of FLIM to assess autofluorescence lifetimes with elastic net
provides insights into the biomolecular interplay underlying different stages of cancer.
The decrease in lifetime for bound FAD might be attributed to several possible
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reasons;44 quenching by an adenine moiety45 or enzymes bound to it.46 Thus the lifetime
in different stages of breast cancer may imply the possibility of quenching or a change in
the microenvironment of FAD due to relevant enzymes binding to it during cancer
progression. This is in accordance with previous studies using a stopped flow analysis
spectrophotometer which suggest a concentration change of bound FAD and the
formation of FAD bound intermediary during the coenzyme oxidation dependent
reaction.47 The lifetime of protein bound FAD is also influenced by the level of NAD+.33 The
increase in FAD bound lifetime also indicates a decrease in the intermolecular dynamic
quenching in the presence of NAD+.48 Our results suggest a decrease in the NAD+ level
with breast cancer progression indicative of elevated mitochondria activity in the electron
transport chain during cancer progression.49
An increase in the lifetime of free FAD and FMN can also be attributed to the
change in the concentration of the quencher, for example, a change in local pH, local
temperature, oxygen, tryptophan, tyrosine, in different stages of cancer.45 A previous
study using RT-PCR shows a decrease in the expression of ESR1 with cancer progression
implying a change in the concentration of FAD with breast cancer malignancy.50 Western
blot, mRNA expression and immunocytochemistry also suggest a dynamic change in
mitochondria related metabolites during breast cancer progression.50–52
The dynamic change in the mitochondria related flavin metabolite coenzyme, FAD,
during different stages of breast cancer progression is in agreement with the previous
study incorporating western blot and mRNA quantification, suggesting that malignancy in
breast cancer is associated with the defects of mitochondria oxidative phosphorylation
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necessitating a change in mitochondria related metabolite levels with the genesis of
breast cancer malignancy.45,46 The relatively constant value of semiquinone can be
attributed to the fact that, it is usually in fast equilibrium with the oxidized and reduced
flavin.12 Therefore, its lifetime may be insensitive to changes in the microenvironment, or
the change is beyond our instrument resolution because it could be in the picoseconds
range.
Elastic net Analysis results show mostly a positive coefficient for cancer cells which
indicates that the correct classification of cancer cells can be attributed to the bound
higher lifetimes compared to others suggesting that the bound FAD plays a major role in
discriminating cancer cells from the rest of the classes considered. Because bound FAD
relates to the activity of the mitochondria related coenzyme, FAD; higher number of
bound FAD could indicate the elevated activity of mitochondria in cancer cells which is in
agreement with previous work using other conventional techniques.50–51 Observation of
lower lifetimes in cancer cells compared to other cells that contribute to the correct
classification of cancer cells has also been noted. This result is supported with
quantification results that show the lifetimes of FAD and FMN to be lower in cancer cells
compared to other groups, and the contribution of these lifetimes is higher in cancer cells
compared to other cells (Fig. 4). Transformed cells show similar contribution from
negative and positive peaks, indicating that correct classification of transformed cells can
be attributed to short and long lifetimes. It can also be seen that the lifetime of FAD, FMN,
and bound FAD for MCF10AneoT cells is at the mid-range compared to that of MCF10A
and MCF10CA1h cells. The predominantly negative coefficient for a normal cell indicates
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that the protein bound FAD has a major contribution towards the classification of normal
cells in MCF10 cell lines (MCF10A), because of a possible decrease in the bound FAD in
MCF10A (P < 0.05) compared to premalignant or malignant cells. This fact can be
associated with normal mitochondrial activity in a normal cell.33
2.5 Conclusions
Our results suggest a FLIM-based method with sufficient resolution for label-free
classification of breast cancer cells in different stages of tumor development. A
classification performance of 100% for cancer, 87% for pre-malignant, and 88% for normal
cells was possible. Elastic net Analysis revealed that the mitochondria related metabolite,
FAD and its other redox forms are potential variables that contribute to classification
accuracy. Analyses further show that, FAD is a major contributor for correct classification
of cancer and normal cells, while more complex metabolites contribute to the
classification of pre-malignant cells.
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CHAPTER 3. FLUROESCENCE LIFETIME IMAGING OF BIOSENSOR PEPTIDE
PHOSPHORYLATION IN SINGLE LIVE CELLS

3.1 Abstract
Phosphorylation of a Cy5-labeled Abl kinase peptide biosensor resulted in an extension
of fluorescence lifetime in live cells. Time-correlated single photon counting fluorescence
lifetime imaging (FLIM) enabled excellent signal-to-noise to visualize the subcellular
patterns of this sensor (see picture). This strategy should be generalizable to other
peptide-based kinase substrates for imaging of kinase activity in single cells.
3.2 Introduction
Many cancers exhibit deregulated activity of protein kinase enzymes, but not all are
sensitive to inhibitor drugs, largely because phosphorylation dynamics in complex tissues
are not well understood.1 Live, subcellular analysis can reveal the details of kinase
signaling in mixed populations of cells.2 Current tools to image kinase activity in situ
depend on intensity-based measurements (such as fluorescence and Förster resonance
energy transfer) that can be limited by spectral bleed-through and photobleaching.3 We
report a cell-penetrating peptide biosensor for dynamic monitoring of phosphorylation
by Abl kinase based on fluorescence lifetime imaging microscopy (FLIM).4 FLIM, which is
not confounded by photobleaching or cellular autofluorescence, was applied to detect
phosphorylation-dependent fluorophore lifetime shifts (1–2 ns) in intact, living cells
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(Figure 1). We established the dependence of the fluorophore lifetime shift on
phosphorylation specifically by Abl kinase, mapped the fluorophore intensity and lifetime
components to quantify subcellular phosphorylation, and monitored kinase inhibition in
real time. This approach should be generalizable to other kinases and provides a new
method for interrogating real-time, subcellular signaling activities in cell populations that
are not amenable to expression of genetically engineered biosensor proteins.

Figure 3.1. FLIM to detect phosphorylation-dependent fluorophore lifetime shifts for
biosensors in intact, live cells. A fluorophore-labeled peptide substrate is delivered to live
cells by a cell-penetrating peptide. Phosphorylation of the substrate results in observation
of increased fluorophore lifetime by FLIM.
Measuring subcellular kinase activity in living cells remains a major challenge. Genetically
encoded Förster resonance energy transfer (FRET) biosensors can be used for this
purpose in simple cell-based assays and basic research applications.3, 5 These sensors take
advantage of binding between phosphorylated sequences and phosphopeptide binding
domains to bring two fluorescent proteins close enough for energy transfer to occur.
However, expressing genetically engineered proteins in cells has challenges, including a)
uniform transfection and expression of protein fluorophores (a roadblock for applications
in primary patient-derived cells or tissues) and b) the large labels which can affect
substrate function and interaction with a kinase.5, 6 Small-molecule fluorophores are able

44
in principle to be less disruptive to function, and many are available for which excitation
and emission do not overlap with expressible fluorophores (enabling multiplexed colocalization experiments).7 These have been applied to detect phosphorylation in cells by
fluorescence intensity increases.8
Low signal-to-noise is a limitation of FRET, and intensity-based fluorescence is
confounded by photobleaching when experiments are conducted over long time periods,
making it difficult to interpret subcellular fluctuations at high spatial and temporal
resolution.6 FLIM is not affected by photobleaching or intensity and has the potential for
single molecule monitoring.4, 9 Also, time-correlated single photon counting FLIM is
capable of highly resolved discrimination between species exhibiting very small
differences in lifetimes (even sub-nanosecond), facilitating the mapping of exquisite
detail in subcellular images. Here we describe the first demonstration of a FLIM-based
phosphorylation biosensor technology that has the potential to circumvent key
technological gaps as a new strategy for studying intracellular signaling biology.
We combined the delivery of organic fluorophore-tagged kinase substrate peptide probes
with time-resolved FLIM to visualize the details of kinase activity in live, intact cells (Figure
1). The biosensor consists of an Abl substrate peptide containing the “Abltide” substrate
sequence10 tagged with a Cy5 fluorophore and a cell-penetrating peptide (Abl-TAT:
GGEAIYAAPCCy5GGRKKRRQRRRPQ) (Figure 2).11 The substrate portion (bold) is relatively
selective for the c-Abl kinase (Abl1) over other tyrosine kinases, however it is
phosphorylated by the Abl family member named Abl-related gene (Arg, also known as
Abl2).12 Abl1 and Abl2 are highly homologous and share many functions in normal
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cells.13 In this work, “Abl kinase” denotes both Abl1 and Abl2. We used FLIM
instrumentation with picosecond pulsing lasers9a,b to measure Cy5 lifetime for the
unphosphorylated biosensor and a phosphorylated derivative in solution and in live cells.

Figure 3.2. Peptide-based Abl kinase biosensor. The biosensor (left) contains an Abl
substrate sequence linked to the TAT peptide for cellular delivery. A Y→F mutated analog
(right) was used to test for tyrosine phosphorylation dependence; a synthetically
phosphorylated derivative (middle) was used as a positive control.
2.3 Materials and Methods
Cell culture. Control (vector only), FKBP-Abl(NUK) and Abl (−/−) immortalized mouse
embryonic fibroblast (MEF) cell lines15 were a kind gift from Prof. Jean Y. Wang
(University of California, San Diego). Cells were maintained in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 1 % penicillin/streptomycin and 10 % Fetal Bovine
Serum (Atlanta Biologicals, Inc.).
Peptide synthesis. Peptides were prepared to >90 % purity using Fmoc solid phase
peptide synthesis as previously described, and labeled with Cy5-maleimide (Lumiprobe,
Inc.,

Hallendale

Beach,

USA)

as

described

in

the

Supporting

Information.11a Characterization details for labeled material are provided in the
Supporting Information.
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FLIM experiments. Imaging was performed using scanning confocal time resolved
microscopy (Microtime 200 from Picoquant GmbH, Berlin, Germany).20 A 633 nm 20
MHz picosecond pulse laser source was used for excitation and emission was separated
from the excitation beam by a dual band dichroic (z467/638rpc, Chroma) and collected
through an apochromatic 60×, 1.2 NA water immersion objective. A 50 μm pinhole was
used to reject off-focus photons from the excitation volume, and the overall fluorescence
was collected and separated accordingly using a dichroic beam splitter (600 cxr, AHF,
Chroma) and filtered by emission filters (685±35 nm) before being detected by two single
photon avalanche photodiodes (SPAD) (SPCM-AQR, PerkinElmer Inc.). Fluorescence was
measured using the time-correlated single photon counting (TCSPC) time-tagged timeresolved (TTTR) mode (Time Harp200, PicoQuant). Fluorescence lifetime was calculated
by fitting TCSPC histograms for each pixel (150×150 pixels total) with a multiexponential
model until no pattern of residual is observed (for example see Figure S7). The 150×150
pixel lifetime images were then converted into a matrix form and exported to MATLAB
R2011b. The data in the matrices were separated and classified into lifetime and intensity
images for visualization and analysis. Notably, images with higher lifetime but lower
intensity thresholds are not easily interpreted using conventional FLIM data, thus this
extraction process enables quantitative analysis.
After this conversion, the intensity components for each experiment were compared to
those of a baseline control (autofluorescence from the cells) to remove background.
Autofluorescence for 3T3 cells ranged from 50–100 intensity counts and this value was
used as a threshold to remove components from the lifetime image with intensity counts
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under 80 to minimize contribution to the signal from autofluorescence. After this
background removal the 2D images were reconstructed using MATLAB and Image J v. 1.42.
Regions of interest (ROIs) comprising an area equivalent to 5×5–10×10 pixels were chosen
for the same general subcellular compartment for different cells (see Figure S8 for
example). At least 20 (20–150) different fitted points in each cell from at least 3 cells per
view were used, and the data were combined for 3–5 replicate experiments to construct
the fitted data comparison shown in Figure 3 G and H in conjunction with representative
images (Figure 3 A–F and Figure S2A).
Biosensor lifetime analyses. For in cell analysis, MEFs were plated on cover slips in 12well plates at 70 % confluency and allowed to recover for 24 h. Wells were washed gently
with PBS (3×1 mL) and treated with probe or controls (Abl-TAT, Abl-phospho, Abl-Fmutant, Cy5 alone) (50 nM) in DMEM with FBS for 24 h. Cover slips were washed with PBS
and imaged immediately. For imatinib experiments, images were taken before the
addition of imatinib to the buffer in which the cover slips were incubated followed by
time lapse imaging after addition of imatinib. Control experiments were conducted
without imatinib to evaluate the potential for and effect of photobleaching over the
experimental time.
Peptide labeling with Cy5-maleimide. Peptide (7-10 mg) was dissolved to a final
concentration of 1 mM in reaction buffer (2 ml, 6M guanidinium-HCl/100mM phosphate)
containing triscarboxyethylphosphine (TCEP, 1 mM) and adjusted to pH 6.5 with
HCl/NaOH as necessary. Cy5- maleimide (1-2 mg, Lumiprobe, Inc., USA) was dissolved in
DMSO (20 µl) and added, and the solution vortexed to mix. The reaction was allowed to
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proceed in the dark at room temperature for 10 h. Reaction progress was checked at 2 h
by analyzing an aliquot (1 µl) diluted into water/acetonitrile/trifluoroacetic acid
(50/50/0.1%) by MALDI-TOF-MS (linear positive mode) using α- cyano-4-hydroxycinnamic
acid as matrix. Labeled peptide was purified by preparative HPLC using a C18 column
(Agilent 1200 system with Agilent Zorbax column) and fractions containing predominantly
labeled material (as detected by MALDI-TOF MS) were pooled and lyophilized to give 1-2
mg final peptide. Identity and purity were initially confirmed by MALDI-TOF MS. After
long-term storage (10 months) in phosphate buffered saline at -20 o C, samples were
analyzed by LC/MS (ThermoFinnegan Accela-LTQ system) on a C18 column (2.1 I.D. x 50
mm L, 1.7µm particle size, Phenomenex) with a gradient of water/acetonitrile/formic acid
(initially 95/5/0.1% rising to 35/65/0.1% at a rate of 6%/min).
3.4 Results and Discussion
In

solution,

lifetime

differences

between

the

phosphorylated

and

unphosphorylated Abl-TAT peptide species were not significant (see Supporting
Information, Figure S1a), indicating that phosphorylation alone is not sufficient to elicit a
change in the rate of fluorescence signal decay for the Abl-TAT peptide sensor. However,
in the presence of c-Abl kinase at 1:1 ratio, robust lifetime differences were observed,
and this phenomenon was blocked by pre-incubation of the kinase with higher ratios of
unlabeled phosphopeptide (Figure S1b). This effect likely arises from the more drastic
change in the local environment of the fluorophore that could occur upon binding of the
phosphopeptide with the protein, probably through the kinase SH2 domain.14
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Since the physicochemical basis for the lifetime shift was still somewhat unknown,
standards were established in NIH3T3 immortalized mouse embryonic fibroblast cells
(MEFs)15 to assess phosphorylation- and Abl kinase-dependence of the lifetime shifts by
using three key negative controls (which exhibited lower lifetimes in cells): Cy5 alone, a
non-phosphorylatable Y→F peptide sensor analog (Abl-F-mutant) (both in control MEFs
expressing Abl kinase) and the Abl-TAT biosensor in Abl(−/−) knockout cells15 (Figure 3 B,
C, and E and Figure S2). Average lifetimes per cell for multiple cells were calculated and
plotted to show the distribution of lifetimes observed for the biosensor and each control
(Figure 3 G). The distributions were determined to be non-Gaussian, so non-parametric
ANOVA with a Dunn’s post-test (described in the Experimental Section) was used to
evaluate statistical significance (P<0.05) for differences in the mean lifetimes. There was
no significant difference between the Cy5, Abl(−/−) or Abl-F-mutant experiments,
however each of these controls exhibited significantly lower mean lifetimes than both
Abl-TAT (in MEFs expressing Abl kinase) and Abl-phospho (positive control). The mean
lifetime for Abl-phospho was also significantly longer than that of Abl-TAT, consistent with
enrichment of the phosphorylated form of the substrate. These experiments confirmed
that the increase in Cy5 lifetime was specific and due to Abl dependent phosphorylation
of the biosensor peptide on tyrosine. As another control to support the interpretation of
phosphorylation

dependence

for

lifetime

increases

in

cells,

we

used

immunocytochemistry to show co-localization between the Abl-TAT biosensor and
phosphotyrosine (Figure S3).
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Figure 3.3. FLIM mapping of biosensor phosphorylation. Wild-type (WT) MEF cells (unless
otherwise indicated) were cultured on cover slips and incubated with the biosensor
peptide or a control (as indicated, 50 nM for each) for 24 h, then imaged using the FLIM
system. Data were extracted from raw FLIM images and represented as lifetime maps (A)–
(F): A) autofluorescence, B) Cy5 only, C) Abl-TAT in Abl (−/−) MEFs, D) Abl-TAT in WT MEFs,
E) Abl-F-mutant, F) Abl-phospho. Full color scale for the lifetime range is shown at right.
Raw FLIM images and lifetime color maps with intensity indicated on the z-axis are shown
in Figure S2. G) Fluorophore lifetime per cell was averaged for at least 20 cells in 3–5
replicate experiments and is plotted as a distribution of lifetimes observed in each
condition. Error bars represent standard error of the mean for each lifetime value. H)
Aligned scatter plots of lifetimes for pixels in selected regions of interest (ROIs) within
similar subcellular locations for cells represented in (G). I=intensity, L=lifetime. Error bars
represent standard error of the mean (SEM).
We tested sequestration of the biosensor in endosomes by staining for an
endosomal marker. Minimal, non-exclusive co-localization of the biosensor with
endosomes was observed, indicating that the biosensor peptide was not sequestered
(Figure S3). We also examined peptide degradation, a potential issue in some cell
types16 but not all, as demonstrated from our prior work.11a Controls using fluorescence
correlation spectroscopy (FCS) measured Cy5 alone vs. the Abl-TAT biosensor in MEFs
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(Figure S4), providing evidence that for MEFs, the signal observed for the Abl-TAT
biosensor arose from peptide that was not degraded to free Cy5.17
To quantitatively address the distribution and level of biosensor phosphorylation
in different subcellular regions we separated the intensity and lifetime components of the
signal arising from the FLIM measurements and plotted lifetime values in 2D using
MATLAB (as shown in Figure 3 A–F). We did not observe phosphorylation-dependent
intensity increases for this biosensor either in solution or in cells (Figure S2A) (in contrast
to what has been observed by others).8a, 18 We then used the Abl-TAT biosensor to image
Abl kinase inhibition with the kinase inhibitor imatinib in control MEFs (Figure 4). MEFs
stably expressing a nuclear-enriched Abl kinase mutant, FKBP-Abl(NUK),15 were also
analyzed in the presence of imatinib (see time lapse movie shown in Figure S5). Over the
course of 70 min we detected a general trend towards decreased lifetime overall (e.g.
Figure 4 and Figure S5) and negative lifetime shifts in multiple areas of the cell within the
first few minutes of incubation (Figure S6), consistent with kinase inhibition and
dephosphorylation of the biosensor by phosphatase enzymes (previously observed11a). In
the absence of imatinib, biosensor lifetime was dynamic but overall no significant
decrease in lifetime was observed (Figure 4)
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Figure 3.4. Subcellular Abl inhibition by imatinib. A) MEFs were treated with the biosensor
and imaged before (t=0) or after (t=5, 8 min) adding the Abl inhibitor imatinib. Arrow
shows selected control cell (top panels). B) Plot of lifetime distribution for cells shown as
well as longer timepoints (0–20 min). Additional timepoint images, and plots for several
subcellular ROIs for multiple cells, are shown in the Supporting Information.
3.5 Conclusions
These experiments demonstrate that fluorescence lifetime shifts measured for
the cell-deliverable kinase biosensor are phosphorylation-dependent, yielding dynamic
information about the localization of kinase (and potentially phosphatase) activity in
single living cells. This could make it possible to examine heterogeneous mixtures of cells
to dissect subsets of signaling phenotypes and responses to inhibitors. This approach
should also be generalizable to other kinase substrates and fluorophores, enabling the
future possibility of analyzing more than one kinase-targeted FLIM biosensor at a time.
Currently, we are developing other kinase substrate biosensors (e.g. for the Syk kinase19)
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to expand the application of this strategy and achieve simultaneous detection of multiple
kinase activities in situ.
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3.6 Supporting Information

Figure S3.1 Fluorophore lifetime measurements in solution. A) Bulk solutions of
each peptide were prepared in PBS (50 nM), dropped onto a cover slip. Measurements
were taken by collecting images and lifetimes were averaged for selected ROIs (randomly
chosen from the field of view). These values were plotted and the data are shown as box
and whisker plots, in which the mean is shown as a horizontal line and error bars
represent the minimum and maximum for each. In addition to the four species described
for in-cell experiments, a version of the Abl substrate that lacked the TAT group was also
included as a control for an affect of the TAT group on Cy5 lifetime. Overall the differences
in mean lifetimes were statistically significant (analyzed using one-way ANOVA with
Tukey’s post-test for multiple comparisons).
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Figure S3.2. A) 2D lifetime maps corresponding to Fig. 3 and B) representative bright field
and raw FLIM images from replicate experiments. i) Raw FLIM images shown in A-F (raw
image counts given in parentheses): (A, G) autofluorescence (3), (B, H) Cy5 only (619), (C,
I) Abl-TAT in Abl (-/-) MEFs (836), (D, J) Abl-TAT in WT MEFs (1037), (E, K) Abl-F-mutant
(1240), (F, L) Abl-phospho (300). Data extracted from raw FLIM images shown in G-L as
lifetime/intensity maps: 2.5D plot of intensity (z-axis) color-coded by lifetime (with longer
lifetimes shaded towards red).
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Figure S3.3. Immunocytochemistry controls staining for phosphotyrosine in the presence
of the biosensor and colocalization between the biosensor and endosomes. Cells were
plated on circular cover slips for imaging and after 75% confluency, incubated with
peptide for 24 hours, washed with PBS and fixed in ice cold acetone for 5 min. After
fixation, cells were washed twice (5 minutes each) with ice cold PBS and then incubated
in 2% BSA in TBST for 90 minutes to prevent non-specific binding. Cells were then
incubated at 4o C for 20 hrs at 1:1000 dilution of antiphosphotyrosine-Alexafluor 488
(Biolegend) labeled antibody in PBST solution with 2% BSA. Cells were mounted in the
imaging chamber for imaging. Colocalization analyses were performed using image J
software.
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Figure S3.4. Fluorescence correlation spectroscopy experiments. FCS measurements were
performed using cells incubated with either Cy5 alone (left) or Abl-TAT biosensor (right)
using the Microtime 200 confocal system (Picoquant). 3T3 cells were incubated with Cy5
(5 nM) or Cy5-Abl TAT (5 nM) peptide for 24 hours and their diffusion characteristics were
measured in the cytoplasm area (see inset). The normalized autocorrelation for both Cy5
and Cy5-Abl TAT was fitted with 3D diffusion model
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Figure S3.5. Real-time inhibition of biosensor phosphorylation in a live cell. The biosensor
was incubated with cultured MEF cells (stably transfected with nuclear localizationenriched Abl kinase3 ) as before. Focus was established on a single cell and the cell was
imaged using FLIM pre- (t=0) and post-addition of imatinib (1 µM) every 2-5 min.
Timepoints are given in the upper left corner. The lifetime color code scale was
standardized between images and the intensity threshold set at 200 counts; from the raw
images, intensity ranged between 300-450 counts total and was maintained throughout
the time course (indicating that photobleaching was not a factor). Bright field image of
the cell at the end of the experiment (70 min) shows maintenance of normal morphology.
See supplemental movie S5 for time lapse. Also see supplemental movie file available
online:https://plus.google.com/photos/110476973448933646127/albums/5808140733
446419969?authkey=CJet_56H h7PfHA
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Figure S3.6. Quantification of lifetime changes after imatinib treatment. Additional time
points are shown for the experiment described in Fig. 4 in the manuscript. In the control
not treated with imatinib, lifetimes were dynamic over the course of the experiments.
White boxes denote regions showing fluctuations towards longer lifetimes, while the
central region of the main cell in the image shows some fluctuation towards shorter
lifetime. In the cell treated with imatinib, changes tended towards shorter lifetimes
(highlighted by yellow boxes). Below is a graph of ROIs from multiple cells, showing trends
wards shorter lifetimes in the presence of imatinib. Open triangles denote ROIs from cells
treated with imatinib, open circles (control) denote ROIs from untreated cells.
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Figure S3.7. Representative example of multiexponential fitting. An example of a timeresolved fluorescence decay plot extracted for a single pixel in the ROI (a) and single cell
(entire ROI) (b) used for fitting the lifetime of different probes (Abl peptide, red curve and
Abl mutant peptide, blue curve). In this example, the decay curves for the single pixel (a)
have the same trend as the whole cell average (b). The respective residuals (c, d) from
fitting for the two peptides show no pattern.
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CHAPTER 4. MONITORING AUTOPHOSPORYLATION IN SINGLE LIVE CELL: REAL TIME
FLUORESCENCE LIFETIME IMAGING OF FOCAL ADHESION KINASE BIOSENSOR
PHOSPHORYLATION

4.1 Abstract
Focal adhesion kinase (FAK) is cytoplasmic non-receptor tyrosine kinase essential for
diverse cellular function, especially cell motility, adhesion and migration1. FAK controls
cell motility through its complex multifaceted molecular connection that regulate
dynamic interplay of actin cytoskeleton, cell adhesion site, and membrane protrusion2.
More importantly, FAK serves as receptor-proximal regulator of cell movement, by
transducing extracellular signal that ultimately govern cell motility3. FAK activation from
extracellular signal such as matrix and growth factor is rapid and highly dynamic process.
Current methods4-6 those enable study of FAK activation upon extracellular signal lack
spatiotemporal resolution or the ability to perform multiplex detection. Here we report a
novel approach to monitor FAK signaling dynamic in live cells by measuring real-time
kinase phosphorylation activity of FAK. We utilized the same strategy of our previous work
using Time-Correlated Single Photon Counting (TCSPC) Fluorescence Lifetime Imaging
(FLIM) of peptide biosensor phosphorylation. Using this approach, we offer an intriguing
glimpse into dynamic temporal and spatial aspect of FAK signaling dynamic upon receiving
extracellular cue.
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4.2 Introduction
An increasing body of evidence7-9 advocates that cells are very sensitive to
extracellular mechanical signals. Mechanical signaling within a tissue is crucial for
tensional homeostasis between and within cells, which modulate repertoire of cellular
processes, such as differentiation10, development11, and survival12. FAK phosphorylation
play pivotal roles in transmitting extracellular cue, including mechanical tension, to
variety of intracellular target. Tight control of FAK phosphorylation activity hence warrant
specific cellular response to extracellular stimulation. Therefore, dysregulation of FAK
activity has been implicated in some malignancies such as angiogenesis dependent
diseases13, developmental disorder14, tumor progression and metastasis15, and
neurological disorder16. Small molecule inhibitors17, 18 have been developed to inhibit
FAK activities, results in impeding angiogenesis19 or cell migration20 during tumor
progression or other disease pathogenesis. Understanding the FAK signaling dynamic
upon extracellular cue will be broad interest of scientific endeavors in drug development,
optogenetic, oncology, tissue engineering, cardiovascular, neurological, developmental,
and synthetic biology and toxicology.
Current technology21, 22 to monitor FAK phosphorylation activity mainly focused
on the kinase activity in cell lysate, or utilize genetically encode sensor. The drawbacks of
cell lysate are the loss of spatiotemporal information of FAK activity which is pivotal in
intracellular signal transduction from environmental cue to downstream signaling protein.
On the other hand, real time monitoring can be achieved by genetically modified sensor,
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yet the ease the feasibility to make stable transfection across different cell lines hinder its
application.
Therefore, there is a need for a technology that enable real time monitoring of
FAK activity which can be easily applied in live cell and feasible for more complex system
application such as 3D culture and in-vivo system. To answer such challenge, we
developed peptide biosensors (FAKsor) to monitor real-time phosphorylation activity of
FAK in live cells. We utilize the same approach as in our previous work23 to design TCSPCFLIM (Supplementary Fig.3 and 4) based FAK biosensor. We exploited the characteristic
of FAK autophosphorylation at Tyr397 sites as a potential recognition motif (Fig.1c) of the
sensor. We designed putative peptide substrate contains the Tyr397 phosphorylation site
and its adjacent amino acid (Fig.1c red) that serve as the sensor’s recognition sequence
(Fig 1c. sensor dark blue part). Cellular FAK will identify the putative sequences and
phosphorylate Tyr397. Additionally, to enable live-cell imaging the peptide sensor
included a cell-penetrating peptide sequence. (Fig. 1c. sensor light blue part). As a
reporter, a fluorophore reporter is conjugated to the lysine residue two amino acids
adjacent to Tyr397 phosphorylation site (Supplementary Fig. 1a, b).Based on our previous
work, the proposed working principle of each sensor is: upon phosphorylation by the FAK,
the phospho group in the sensor (phopsho-Tyr) will bind to a phospho-binding domain
which will change the solvatochromic environment of the sensor reporter, hence change
its fluorescence lifetime in a kinase phosphorylation dependent manner 23 (Fig. 1a).
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4.3 Materials and Methods
4.3.1 Peptide Biosensor
Peptide sensors were designed based on our previous work. FAKsor contains a FAK kinase
domain that contains autophopshorylation site. A delivery sequence was then added to
the main kinase-recognition sequence. All peptides were prepared by Alpha Diagnostic
with >90 % purity. Characterization of labeled materials are provided in the Supporting
Information.
4.3.2 In-vitro 2D cell culture
Human endothelial colony forming cells (ECFC) were isolated and cultured as previously
described (REF). Briefly, ECFC were grown in EGM-2 (Lonza, Walkersville, MD)
supplemented with 10% FBS. ECFC were grown in collagen-coated culture flasks. ECFCs
were passaged at 80% confluence; passages less than six were used. HMSC in DMEM low
glucose (Invitrogen) supplemented with 5% FBS, HMSC were passaged at 70% confluence.
HEK 293 and C2C12 cells were cultured in DMEM supplemented with 5% FBS and 1%
Penicillin/Streptomycin. Sunitinib resistant RCC 786-R were cultured in RPMI-1640
supplemented with 5% FBS and 1% Penicillin/Streptomycin. All cell cultures were
maintained at 5% CO2 at 37°C. Prior to imaging, cells were cultured on cover slips (12mm
diameter, 1.5 thickness) in 12 well plate for 24 hours, followed by sensor delivery.
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4.3.3 Sensor delivery
For sensor delivery in 2D cultures, cells were incubated with a peptide sensor Faksor in
the corresponding appropriate culture medium, washed three times with 1× PBS, and
mounted in the imaging chamber.
4.3.4. 2D imaging
Since imaging was performed in live cells, we employed a temperature controlled
chamber (37°C) (INU) adapted onto the stage of either TCSPC-FLIM (Company?) or A1RMP Confocal System (Nikon). Prior to imaging 2D cultures, cells were cultured on glass
coverslips (#1.5) or on the scaffold on top of coverslip and were transferred to live-cell
chamber disk (courtesy of Dr. Paul Robinson) with fresh medium. Prior to imaging vascular
networks in 3D multi tissue constructs, tissues were transferred to glass bottom dishes
(#1.5; MatTek Corporation) and filled with fresh medium.
4.3.4 Confocal Microscopy
Nikon A1R-MP was used to capture conventional confocal images of 2D cell cultures
(https://www.nikoninstruments.com/Products/Multiphoton/A1RMP-Multiphoton). For
fluorophore excitation, a 488nm for FAksor. Signal from FAksor was collected via
photomultiplier tubes (PMTs). PMT corresponded to a unique detection channels with
emission filter bands of 515/30 nm . Image scanning was conducted in galvano mode
using 512 × 512 pixels @ 4 fps. For all images, the pinhole was set at 1 Airy Unit (a.u.). For
2D Images, a 60× oil objective was used.
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4.3.4 TCSPC-FLIM
To perform FLIM of the peptide biosensors we utilized a Time Correlated Single Photon
Counting Fluorescence Lifetime Imaging (TCSPC-FLIM) system (MicroTime 200, Picoquant,
Germany) that allowed precise time measurements of i) when fluorophores were excited
and ii) when photons first arrived at the detector. Photon excitation was achieved via a
pulsed picosecond diode laser (460 nm 40 MHz). The laser was coupled to the main
MicroTime 200 Unit as previously described () and is described in Supplementary Fig 10.
Briefly, a dichroic mirror (1P-dichroic, Chroma) was used to reflect a laser beam through
a long working distance objective (50x, 1.45 NA, Olympus) and into the sample. Images
were acquired via raster scanning with XY-Piezo nanopositioning stage (Physik
Instrumente, Germany). Fluorescence was collected by the same objective and emitted
photons were transmitted by a dichroic mirror (1-P-dichroic, Chroma), through a 50-µm
pinhole, and directed into two single photon avalanche diode detectors (SPAD, SPCMAQR, PerkinElmer Inc.). To collect emitted photons from the FAM-5 fluorescent reporter,
a 520±60 nm filter was placed in front of SPAD 1. The captured photons were then
processed by TimeHarp 260 PC-board (Picoquant, Germany) using TCSPC and the data
was stored in Time Tagged Time Resolved (TTTR) mode. Data analysis to obtain
fluorescence lifetime was performed with SymPho Time (A Symphony of Photons in Time)
software (Picoquant, Germany).
To obtain pixel-by-pixel average fluorescence lifetime, the experimental fluorescence
decay curve was fitted with a multiexponential model. Specifically, a non-linear least
squares analysis employing iterative Levenberg–Marquardt routine was used to do a
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pixel-by-pixel fitting of the experimentally observe fluorescence decay. LevenbergMarquadt was chosen for its computational efficiency (Supplementary Fig 10). The
equation used for this model is:

where I(t) is the fluorescence intensity at time after excitation pulse, and n is the total
number of decay components in the exponential sum. The variables τi and αi are the
fluorescence lifetime and fractional contribution of the i-th emitting species, respectively.
In this work, bi-exponential model was chosen to fit the experimental decay to obtain the
average fluorescence lifetime per pixel. Assessment of fitting was done by minimizing the
Chi-square value. To ensure unbiased fitting, we excluded Chi-square values greater than
1.3. The average fluorescence lifetime was determined in each cell, with a minimum of
100 cells in each of the groups. For average fluorescence lifetime of subcellular regions,
the subcellular Region of Interest (ROI) was determined using SymphoTime software, it’s
corresponding decay information was extracted and fitted to obtain respective average
fluorescence lifetime of the ROI.
4.3.5 Statistic
For 2D experiments at least 100 cells from 3 different biological replicates was used for
analysis. To compare means among different groups, an ANOVA was completed (α=0.05)
with a Fisher least significant difference (LSD) post-hoc test to determine groups that
were statistically different from each other.
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4.4 Results and Discussion
A challenge for genetically encoded or nanoparticle-based sensors is achieving uniform
uptake between different cell lines24, 25. The efficacy of cellular delivery for FAKsor was
tested in five different cell lines (Supplementary Fig. 6). Sensor was rapidly internalized
across cellular membrane within 20 minutes. To validate subcellular localization, cells
were stained via immunofluorescence and visualized with confocal microscopy
(Supplementary Fig. 7).
To assess phosphorylation and FAK kinase –dependence of the FAksor fluorescence
lifetime shifts a positive control was used in three different cells, FAK-specific small
molecule activator (Angiotensin II). Upon cells pretreatment with Angiotensin II for 1 hour,
internalized FAKsor exhibited a longer fluorescence lifetime compared to non-treated
control (Fig. 2, Supplementary Fig. 8,9). Two negative controls were implemented 1) an
FAK-specific inhibitor, FI-14, and 2) a non-phosphorylatable mutant FAKsor peptide were
used (Fig. 1, Supplementary Fig. 2a,b). When compared to Angiotensin II stimulated cells
(Fig.1a,d,e, 3.9 ns), negative controls for FAksor demonstrated decreased fluorescence
lifetime with FI-14 at 3.2 ns (Fig.2h) and the mutant FAKsor at 2.9 ns (Fig.1b,d,e,2b).
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Figure 4.1|Proof of concepts. (a), (b), (d), (e) Monitoring FAK phosphorylation in 2D cell
culture.FAksor fluorescence lifetime is phosphorylation dependent in live 2D ECFC cell.
Fluorescence lifetime images of FAksor in 2D ECFC (a,b) after cell treatment with
Angiotensin II (1 µM , 30 min) demonstrate higheraverage fluorescence lifetime of FAKsor
(3.8 ns) (a)compared to non-phopshorylatableFAKsor mutant (2.9 ns) (b). (c) Schematic
cartoon depicting FAK FERM-Kinase domain (blue) including Tyr-397 autophosphorylation site (red). Putative peptide sensor was designed by including Tyr-397 and
its adjacent amino acids as the sensor recognition sequence (dark blue) conjugated with
TAT sequences to enable live cell imaging. Mutant sensor was designed by replacing
tyrosine site to phenylalanine (Y-F) (orange). (d) Fluorescence decay of FAKsor (blue)
shows longer fluorescence decay (red) upon kinase phosphorylation compare to control
mutant FAKsor (orange) (e) Fluorophore lifetime of FAKsor (orange) and mutant
FAKsor(blue) per cell was averaged for at least 50 cells in 3 replicates experiments and is
plotted as a distribution of lifetimes observed after cells treatment with Angiotensin II
(1 µM, 30 min).
Moreover, FAKsor exhibited decrease in its fluorescence lifetime upon inhibitor
treatment in dose dependent manner (Fig.2c-h, j). Histogram of average fluorescence
lifetime of FAKsor in approximately 100 cells for each condition (Fig.2i) demonstrated
FAKsor fluorescence lifetime dependent of FAK phosphorylation, by showing higher
average fluorescence lifetime (3.9 ns) of FAKSor in ECFC treated with FAK phosphorylation
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activator, Angiotensin II (orange), compared to FAKSor fluorescence lifetime (3.19 ns) in
ECFC treated with FAK phosphorylation inhibitor, FI-14(green), and compared to FAKsor
mutant (Y-F) average fluorescence lifetime (2.97 ns) in Angiotensin II treated ECFC
(yellow). The average fluorescence lifetime difference between each treatment group is
statistically significant (P <0.001).
Real time tracking was performed for FAKsor in three different cell line,
Endothelial Coloy Forming Cells (ECFC), Human Mesenchymal Stem Cell (HMSC) and
Musculoskeletal cell (C2C12). In ECFC, FAKsor was internalized and exhibited increased
fluorescence lifetime 25 minutes after stimulation with Angiotensin(II) compared to nontreated ECFC as control (Fig.3 a). In addition to monitoring the temporal dynamic of
FAKsor signal, distinct FAKsor spatial profiles indicated its nuclear activation (Fig. 3a) after
15 minutes’ of stimulation with 20 ng/mL 1µM Angiotensin II. This finding is in
concordance with previous findings of FAK nuclear localization and activation26.
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Figure 4.2|Fluorescence lifetime changes of FAKsor depends on FAK acetylation in 2D
ECFC cells. (a-h) Fluorescence lifetime images for different treatment; Positive controls
for FAKsor, 1 µM treatment Angiotensin II (c), shows higher average florescence lifetime
(3.9 ns) when compared to control FAKsor without Angiotensin II (a,3.4 ns) and negative
control mutant FAKsor (b, 3.1ns). (d-h) Treatment with FI-14 (90 minutes), an Tyr397
inhibitor, decrease FAksor average fluorescence lifetime in a dose-dependent manner (d)
500 nM (3.75 ns), (e) 1 µM (3.6 ns), (f) 3 µM (3.58 ns), (g) 5 µM (3.45 ns), (h) 10 µM (3.38
ns) (I,j) Quantitative analysis; (i) Fluorophore lifetime per cell was averaged for at least 50
cells in 3 replicates experiments and is plotted as a distribution of lifetimes observed in
different condition, (j) Quantitative analysis shows average fluorescence lifetime for
different treatments (n=100)
Quantitative analysis (Fig.3c) confirmed that FAKsor in ECFCs treated with
Angiotensin II (orange line) not only have a higher average fluorescence than the control,
but also experience detectable changes from the initial average fluorescence lifetime (3.1
ns to 3.9 ns). On the other hand, the control does not show any noticeable change in
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average lifetime over the 25-minute time course (green line). This observation is
representative of three technical replicate and three independent biological replicate. As
negative control, real time observations in three different cells was also conducted for
FAKsor using FI-14, a FAK phosphorylation inhibitor, treatment. Fluorescence lifetime
images of internalized FAKSor in ECFC exhibited decreased fluorescence lifetime 25
minutes after treatment with FI-14 compared to control, non-treated ECFC (Fig. 3b).
Quantitative analysis (Fig. 3d) validated FLIM images observation that FAKsor in ECFC
treated with FI-14 (orange not only has lower fluorescence lifetime compared to control
but also exhibit detectable decrease from initial average fluorescence lifetime (3.9 ns to
3.34 ns). On the other hand, the control does not show any noticeable decrease in average
lifetime over the 25-minute time course (green line). This observation is representative
of three technical replicate and three independent biological replicate. The same realtime observation for 25 minutes was performed in two others different cells line HMSC
(Supplementary Fig.9 a-c) and C2C12 (Supplementary Fig.10a-c) and similar trend was
observed. These positive and negative control experiments demonstrated that FAKsor
fluorescence lifetime is phosphorylation and FAK kinase dependent.
After validating FAKsor performance, we applied FAKsor to monitor FAK phosphorylation
in musculoskeletal cells upon extracellular environmental tension. FAKsor average
fluorescence lifetime was monitor in the different growth substrate; plastic and PEG
based scaffold (Supplementary Fig.10 a, b).
FLIM images (Supplementary Fig.10 a-d) and quantitative analysis (Supplementary
Fig.10 e, f) show that internalized FAKsor in musculoskeletal cells exhibited higher average
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fluorescence lifetime when the cells were grown on scaffold (Supplementary Fig.10b)
compared to plastic substrate (Supplementary Fig.10 a). This results suggest that the
tension from scaffold induced higher activity FAK phosphorylation in musculoskeletal cells.
Interestingly, real time monitoring of FAKsor fluorescence lifetime on the scaffold reveal
dynamic of FAK phosphorylation with different FAKsor fluorescence lifetime in different
state of cell phenotype (Supplementary Fig. 10 c, d, f, Supplementary Video 1). These
results suggest the ability of FAKsor in giving the information of FAK phosphorylation
dynamic upon cells exposure to extracellular cue, in this case, tension from scaffold.
We have developed an approach to monitor real time FAK signaling upon
extracellular cue, either chemical trigger or extracellular tension. To the best of our
knowledge, no other non-genetically encoded bio-sensing methodology is available to
monitor real-time FAK dynamic phosphorylation has been reported before.
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Figure 4.3. Fluorescence lifetime shifts of FAKsor is FAK phosphorylation dependent. (a),
(b) Real time measurement of FAksor fluorescence lifetime in ECFC show increase (a) and
decrease (b) average florescence lifetime in Angiotensin II (a) and FI14 inhibitor (b)treated
cells over 25minutes’ observation. (c)quantitative analysis reveal 1µM Angiotensin II
treatment (orange line and dot) in ECFC increase average fluorescence lifetime (3 ns to
3.9 ns) in 25 minutes compare to control which does not show change in its general trend
of average lifetime over 25minutes’ observation (green line and dot). (d) average lifetime
of FAKsor decrease in 25 minutes (orange line and dot) after cell treatment with FI14
compare to control (green line with dot) This observation is representative of three
technical replicate and three independent biological replicate.
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4.5 Conclusions
Our approach provides spatio-temporal dynamic of FAK activity which allow us to
interrogate when and where signaling event occur, especially upon extracellular trigger.
This approach can be applied into more complex model such as 3D culture and in-vivo
studies to monitor FAK dynamic upon more complex extracellular cue. Moreover, this
methodology can be translated into more complex interaction between FAK activation
and its downstream signaling upon signal transduction by environmental cue by
expanding the number of kinase sensors and choosing fluorophore reporters with
different dynamic range of their respected fluorescence lifetime.

4.6 Supplementary Information

Supplementary Figure 4.1a|MALDI –TOF characterization of purified of FAKsor
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Supplementary Figure 4.1b|HPLC characterization of purified of FAKsor
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Supplementary Figure 4.1a|MALDI –TOF characterization of purified of FAKsor mutant
Y-F
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Supplementary Figure 4.1b|HPLC characterization of purified of FAKsor mutant Y-F
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Supplementary Figure 4.3. Schematic of Time Correlated Single Photon Counting
Fluorescence Lifetime Imaging (TCSPC-FLIM) system (Picoquant, Germany). Photon
excitation was realized by pulsed picosecond diode laser (460 nm and 637 nm; 40 MHz).
The laser was coupled to the main MicroTime 200 Unit.Images were acquired by raster
scanning with XY-Piezo nanopositioning stage (Physik Instrumente, Germany), which
allow X-, Y-, and Z-movement precision with 80 µm range and X,Y,Z resolution less than
10 nm.Laser beam was reflected toward objective using dichroic mirror (1P-dichroic,
Chroma) and then focused into the sample through long working distance objective (50x,
1.2 NA, Olympus). Fluorescence was collected by the same objective and the emission
wavelength was transmitted by dichroic mirror (1-P-dichroic, Chroma). The emitted light
was guided through 50 µm pinhole and directed into two single photon avalanche diode
detectors (SPAD,SPCM-AQR, PerkinElmer Inc.). A 520±60 nm emission filter was placed in
front of SPAD 1 to collect signal from FAM-5 while a 685±50 nm filter was placed in front
of SPAD 2 to collect emission from the Cy5 fluorophore. The emitted photonswerethen
processed by TimeHarp 260 PC-board (Picoquant, Germany) using time correlated single
photon counting method. The photon data was then stored in Time Tagged Time Resolved
(TTTR) mode. The pixel by pixel data was then stored in the CPU and was further fitted
using SymphoTime software
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Supplementary Figure 4.4. Schematic of method to quantify FLIM images. (a) FLIM
images collected with TCSPC was fitted pixel by pixel to obtain lifetime per pixel in cells.
Average lifetime per cell was determined by averaging lifetime of 22,500 pixels (n=100
cells). (b) For subcellular quantification, fluorescence decay curves foreach designated
region of interest was fitted to obtain average lifetime. (c) Example of fitting experimental
decay with a bi-exponential model employing Levenberg-Marquadt algorithm. The fit was
performed such that there was i) sufficient Chi value (<1.3) and ii) no residual pattern (d)
was observed
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Supplementary Figure 4.5. No pattern was observed for residual of decay fitting of (a)
FAksor (b) FAksor mutant Y-F
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Supplementary Figure 4.6| FAKsor are rapidly internalized (20 min) by different cell
types. (a-f) Fluorescence lifetime images after 20 minutes’ incubation period of FAksor at
37oC (b) (20 µM each) in different cell types cultured on 2D glass coverslips at 37oC
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Supplementary Figure 4.7| Subcellular localization of FAK in ECFC visualized by
Immunofluorescence. In both cells FAK is localized in the nucleus and cytoplasm,
consistent with the subcellular localization of FAKsor. The observation was consistent
throughout all samples (n=100).
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Supplementary Figure 4.8. Real time monitoring of FAKsor for 25 minutes in C2C12 upon
treatment with FAK inhibitor F-14. Fluorescence lifetime time-course images of FAksor
treated with FI-14 (b) show an overall trend of decreasing fluorescence lifetime for FAKsor
compare to non treated cell control (a). Quantitative analysis show a decrease in FAKsor
fluorescence lifetime after FI-14 treatment over 25 mintues period compared to control,
Data representative of three independent biological replicate and three technical
replicates.
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Supplementary Figure 4.9. Real time monitoring of FAKsor for 25 minutes in HMSC upon
treatment with FAK inhibitor F-14. Fluorescence lifetime time-course images of FAksor
treated with FI-14 (b) show an overall trend of decreasing fluorescence lifetime for FAKsor
compare to non-treated cell control (a). Quantitative analysis shows a decrease in FAKsor
fluorescence lifetime after FI-14 treatment over 25 mintues period compared to control,
Data representative of three independent biological replicate and three technical
replicates.

88

Supplementary Figure 4.10. FAksor fluorescence lifetime is dependent of FAK
phopshorylation and FAK phosphorylation is dependent upon extracellular matrix
stiffness. Fluorescence lifetime images of FAKsor in C2C12 cells cultured on different
substrate; (a) plastic (b) PEG scaffold. FAK phosphorylation is dynamically changed in
different state of cell morphology
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CHAPTER 5 KEEPING TRACK OF KINASE SIGNALING DYNAMIC IN-VIVO: REAL TIME
MULTIPLEX FLUORESCENCE LIFETIME IMAGING OF PEPTIDES BIOSENSOR
PHOSPHORYLATION

5.1 Abstract
Protein kinases are tightly regulated signaling proteins that play a central role in cellular
signaling pathways through their phosphorylation activity. Distinct spatial and temporal
activation profiles of the same repertoire of protein kinases results in diverse cellular
response1.Dysregulation of protein kinase spatial and temporal activation thus result in
the malfunction of kinase-mediated signaling pathways which lead to a variety of human
diseases2. Therefore, it is necessary to find an approach to interrogate spatial and
temporal dynamics of protein kinase signaling cascades. Current methods3,4to study
kinase signaling lack spatiotemporal resolution or the ability to perform multiplex
detection. Here we report a novel approach to monitor VEGFR-2 –AKT kinase signaling
cascade in-vivo by measuring real-time multiplex kinase activity of VEGFR-2 and AKT. We
utilized the same strategy of our previous work5using Time-Correlated Single Photon
Counting (TCSPC) Fluorescence Lifetime Imaging (FLIM) of peptide biosensor
phosphorylation. Using this approach, we offer an intriguing glimpse into dynamic
temporal and spatial aspect of signaling cascade between VEGFR-2 and AKT not only in2D
and 3D cell culture models, but also in an in-vivo model, namely the zebrafish.
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5.2 Introduction
Pivotal cellular decisions such as cell proliferation, migration, apoptosis, and other diverse
physiological functions rely on precise control of cellular response to extracellular
stimulation6.The specificity of cellular response to receptor stimulation requires extensive
signaling cascade between receptor and its downstream signaling networks7. VEGFR-2
signaling pathway is pertinent to diverse cellular function, especially blood vessel forming
processes such as vasculogenesis and angiogenesis8.Small molecule inhibitors have been
developed to inhibit VEGFR-2 activities, impeding angiogenesis during tumor progression9.
AKT is a downstream signaling protein of VEGFR-2, which is shared by multiple other
pathways10. Understanding the VEGFR-2 downstream signaling cascade to AKT behavior
will be broad interest of scientific endeavors in drug development, oncology,
developmental and synthetic biology and toxicology. In order to monitor VEGFR-2 and
AKT signaling cascades, we developed biosensors to monitor real-time phosphorylation
activity of VEGFR-2 (Vsor) and AKT (Asor).
We utilize the same approach as in our previous work5to design FLIM basedbiosensor
Vsor and Asor. For each kinase, the specific peptide substrate contains the
phosphorylation site, serine for AKT11, and tyrosine for VEGFR-212. Additionally, to enable
live-cell imaging the peptide included a cell-penetrating peptide sequence. (Fig. 1b (inset)).
In each sensor, a fluorophore reporter is conjugated to the lysine residue adjacent to
phosphorylation site (Supplementary Fig. 1a-d). Based on our previous work, the
proposed working principle of each sensor is: upon phosphorylation by the target kinase,
the phospho group in the sensor will bind toa phospho-binding domain which will change
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the solvatochromic environment of the sensor reporter, hence change its fluorescence
lifetime in a kinase phosphorylation dependent manner (5), (Fig. 1a).

5.3 Materials and Methods
5.3.1 Peptide Biosensor
Peptide sensors were designed based on our previous work. Vsor contains a VEGFR-2
kinase domain that contains the phosphorylatable Tyrosine-966 site. A delivery sequence
was then added to the main kinase-recognition sequence. The amino acid sequence for
Vsor is: GRRRAAPEDLYK(5FAM)DFLTGRKKRRQRRRPQ. Asor, the Akt sensor, contains the
phosphorylatable serine site in the main sequence and was also modified with the same
delivery sequence used for Vsor. The amino acid sequence for Asor is:
ARKRERAYSFK(5FAM)HHARKKRRQRRRPQ. For our multiplex biosensor, a different
fluorophore (Cy5,633/685 ex/em) was added to the counterpart of Asor:
ARKRERAYSFK(Cy5)HHARKKRRQRRRPQ.

The

negative

control

was

a

non-

phosphorylatable version of Asor: ARKRERAYCFK(5FAM)HHARKKRRQRRRPQ. On the
other

hand,

the

positive

control

sequence

was

as

follows:

ARKRERAY(Sphospho)FK(5FAM)HHARKKRRQRRRPQ . All peptides were prepared by Alpha
Diagnostic with

>90 % purity. Characterization of labeled materials are provided in the

Supporting Information.
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5.3.2 In-vitro 2D cell culture
Human endothelial colony forming cells (ECFC) were isolated and cultured as previously
described (REF). Briefly, ECFC were grown in EGM-2 (Lonza, Walkersville, MD)
supplemented with 10% FBS. ECFC were grown in collagen-coated culture flasks. ECFCs
were passaged at 80% confluence; passages less than six were used. MCF12A and
MCF12A p53 (-/-) were cultured in DMEM/F12 (Invitrogen) supplemented with 5% Horse
Serum, 20ng/mL EGF, 0.5 mg/mL Hydrocortisone, 100 ng/mL Cholera Toxin, and 100
µg/mL Insulin. MCF12A were passaged at 90% confluence. HEK 293 cells were cultured in
DMEM supplemented with 5% FBS and 1% Penicillin/Streptomycin. Sunitinib resistant
RCC 786-R were cultured in RPMI-1640 supplemented with 5% FBS and 1%
Penicillin/Streptomycin. All cell cultures were maintained at 5% CO2 at 37°C. Prior to
imaging, cells were cultured on cover slips (12mm diameter, 1.5 thickness) in 12 well plate
for 24 hours, followed by sensor delivery. For VEGF stimulation, cells were starved with
VEGF-free medium for one hour, then stimulated with VEGF (Lonza) 20 ng/mL during FLIM
monitoring. For studies involving VEGF inhibition, Axitinib (SCBT) was added into medium
during real time FLIM monitoring. For insulin stimulation, cells were first starved with
serum-free medium for one hour and Insulin 100ng/mL (Sigma) was added before FLIM
monitoring.
For Sunitinib (Pfeizer) inhibition experiment on RCC-780-R, 5µM Sunitinib were added to
medium for 24 hours. After treatment, FLIM images of treated and untreated cells were
taken.
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5.3.3 In-vitro 3D cell culture
3D culture was performed as previously described (Kevin paper) with slight modifications.
Briefly, ECFCs were suspended in neutralized collagen at 5×106 cells/mL, formed into
spheres, polymerized, and subsequently embedded into 48-well plates containing
neutralized collagen. Multi-tissue cultures (sphere + surrounding) were then placed into
an incubator (5% CO¬2; 37°C) to induce collagen matrix polymerization. Afterwards,
500µL EGM-2 was added and replaced daily.
5.3.4 Sensor delivery in 2D and 3D
For sensor delivery in 2D cultures, cells were incubated with a peptide sensor (Asor or
Vsor; 10 µM) in the corresponding appropriate culture medium, washed three times with
1× PBS, and mounted in the imaging chamber. For sensor delivery in 3D cultures, collagen
tissues were incubated with a peptide sensor (Asor or Vsor; 15 µM) for 30 minutes,
washed thrice with 1× PBS, then the appropriate culture medium added before imaging.
5.3.5 2D and 3D imaging
Since imaging was performed in live cells, we employed a temperature controlled
chamber (37°C) (INU) adapted onto the stage of either TCSPC-FLIM (Company?) or A1RMP Confocal System (Nikon). Prior to imaging 2D cultures, cells were cultured on glass
coverslips (#1.5) and were transferred to live-cell chamber disk (courtesy of Dr. Paul
Robinson) with fresh medium. Prior to imaging vascular networks in 3D multitissue
constructs, tissues were transferred to glass bottom dishes (#1.5; MatTek Corporation)
and filled with fresh medium.
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5.3.6 Confocal Microscopy
Nikon

A1R-MP

(https://www.nikoninstruments.com/Products/Multiphoton/A1RMP-

Multiphoton) was used to capture conventional confocal images of 2D and 3D cell
cultures. For fluorophore excitation, a 488nm and 633nm laser was used for Vsor and
Asor, respectively. Signal from Vsor and Asor was collected via two separate
photomultiplier tubes (PMTs). Each PMT corresponded to a unique detection channels
with emission filter bands of 515/30 nm and 685/30 nm for Vsor and Asor, respectively.
Image scanning was conducted in galvano mode using 512 × 512 pixels @ 4 fps. For all
images, the pinhole was set at 1 Airy Unit (a.u.). For 2D Images, a 60× oil objective was
used. For 3D imaging, a combination of 10×, 20× and 60× objectives were used. Confocal
image Z-stacks were acquired to determine spatial distribution of sensor in the ECFC of
the 3D vascular network.
5.3.7 TCSPC-FLIM
To perform FLIM of the peptide biosensors we utilized a Time Correlated Single Photon
Counting Fluorescence Lifetime Imaging (TCSPC-FLIM) system (MicroTime 200, Picoquant,
Germany) that allowed precise time measurements of i) when fluorophores were excited
and ii) when photons first arrived at the detector. Photon excitation was achieved via a
pulsed picosecond diode laser (460 nm and 637 nm; 40 MHz). The laser was coupled to
the main MicroTime 200 Unit as previously described () and is described in Supplementary
Fig 10. Briefly, a dichroic mirror (1P-dichroic, Chroma) was used to reflect a laser beam
through a long working distance objective (50x, 1.45 NA, Olympus) and into the sample.
Images were acquired via raster scanning with XY-Piezo nanopositioning stage (Physik
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Instrumente, Germany). Fluorescence was collected by the same objective and emitted
photons were transmitted by a dichroic mirror (1-P-dichroic, Chroma), through a 50-µm
pinhole, and directed into two single photon avalanche diode detectors (SPAD, SPCMAQR, PerkinElmer Inc.). To collect emitted photons from the FAM-5 fluorescent reporter,
a 520±60 nm filter was placed in front of SPAD 1. For Cy5?, a 685± nm filter was placed in
front of SPAD 2. The captured photons were then processed by TimeHarp 260 PC-board
(Picoquant, Germany) using TCSPC and the data was stored in Time Tagged Time Resolved
(TTTR) mode. Data analysis to obtain fluorescence lifetime was performed with SymPho
Time (A Symphony of Photons in Time) software (Picoquant, Germany).
To obtain pixel-by-pixel average fluorescence lifetime, the experimental fluorescence
decay curve was fitted with a multiexponential model. Specifically, a non-linear least
squares analysis employing iterative Levenberg–Marquardt routine was used to do a
pixel-by-pixel fitting of the experimentally observe fluorescence decay. LevenbergMarquadt was chosen for its computational efficiency (Supplementary Fig 10). The
equation used for this model is:

(1)
where I(t) is the fluorescence intensity at time after excitation pulse, and n is the total
number of decay components in the exponential sum. The variables τi and αi are the
fluorescence lifetime and fractional contribution of the i-th emitting species, respectively.
In this work, bi-exponential model was chosen to fit the experimental decay to obtain the
average fluorescence lifetime per pixel. Assessment of fitting was done by minimizing the
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Chi-square value. To ensure unbiased fitting, we excluded Chi-square values greater than
1.3.
The average fluorescence lifetime was determined in each cell, with a minimum of 100
cells in each of the groups. For average fluorescence lifetime of subcellular regions, the
subcellular Region of Interest (ROI) was determined using SymphoTime software, it’s
corresponding decay information was extracted and fitted to obtain respective average
fluorescence lifetime of the ROI.
5.3.8 Sensor Delivery in-vivo
5.3.8.1 Sensor delivery embryo
5.3.8.2 Preparation of Injection Needle
Needles for microinjection were prepared as follow: borosilicate capillary glasses (World
precision instrument, # 9908344) were pulled with Flaming Brown Micropipette Puller
(get info from Birck) with parameter D= 200, Heat =335, Velocity= 80, and Pull= 110.
Pulled needles were placed on the needle holder until it was used.
5.3.8.3 Microinjection
The peptide biosensors were loaded into needles with micro loader pipette tips
(Eppendorf) and subsequently injected into zebrafish (0.25s; 65 hPa).
5.3.8.4 Embryo Microinjection
We placed 2 hpf eggs into a petri dish containing egg water (0.6 g/L aquarium salt (PetCo)
in DI water) and removed debris with a transfer pipette. A microscope slide (Thermo
Scientific) was placed in the 100mm Petri dish (NuncTM Cell culture, Thermo Scientific).
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A non-plugged pasteur pipet was used arrange the eggs in a single column against the
side of the glass slide. A Kimwipe was used to remove excess egg water.
A microloader tip (Eppendorf) was used to load the needle with 10 µL sensor (Asor, Vsor,
or both). Embryos were then injected with the loaded sensor and placed in warm (37oC)
liquid agarose in glass bottom dish for imaging. After the agarose solidified, the dish was
filled with egg water and the embryo was imaged. To test the sensor toxicity, the embryo
was returned to egg water and kept in 27.5oC.
5.3.8.5 Larvae Microinjection
Larvae were anesthetized in 0.2% MS-222 for 10 minutes until no movement was
detected. Anesthetized larvae were then placed into thin layer 37oC 1% liquid Agarose in
a 100mm Petri dish (NuncTM Cell culture, Thermo Scientific). After the agarose solidified
(about 1-2 minutes), fresh egg water containing 0.2% MS-222 was poured into the dish.
The tip of the needle pierced the periderm, directly into the caudal vein, where the sensor
was injected. Injected sensors followed the blood flow through the caudal vein towards
the heart. The larvae were then repositioned into a very thin layer of 1% Agarose in 35
mm glass bottom dish and egg water containing 0.2% MS-22 was added prior to imaging.
For stimulation experiments, 2.5µL pipet tips were used to eject drops of the stimulant
compound near i) the caudal vein opening and ii) the mouth area. During imaging, a
temperature control chamber was used to keep larvae at 27.5oC.
5.3.9 Statistic
For 2D experiments at least 100 cells from 3 different biological replicates was used for
analysis. For 3D experiments, 3 different technical and 3 different biological replicates
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was performed. For in-vivo experiments, three biological replicates with n=6 zebrafish
was conducted. To compare means among different groups, an ANOVA was completed
(α=0.05) with a Fisher least significant difference (LSD) post-hoc test to determine groups
that were statistically different from each other.
5.4 Results and Discussion
A challenge for genetically encoded or nanoparticle-based sensors is achieving
uniform uptake between different cell lines13, 14.The efficacy of cellular delivery for both
sensors were tested in five different cell lines(Supplementary Fig. 2a, b). Each sensor was
rapidly internalized across cellular membrane within 20 minutes. Interestingly, ach
biosensor entered the cells through distinct mechanisms(Supplementary Fig. 3a-d).Vsor
was internalized via an energy independent process while Asor uptake was through
energy dependent process15. To validate subcellular localization, were stained via
immunofluorescence and visualized with confocal microscopy (Supplementary Fig. 4a, b).
To assess phosphorylation and Akt kinase –dependence of the Asor fluorescence lifetime
shifts, five positive controls were used: phosphorylated Asor peptide, AKT-specific small
molecule activator (Fumonisin B), cell surface receptor agonist (insulin),MCF12a p53 (-/-)
mutant cell with constitutively activeAKT (Supplementary Fig. 5a-e, k)and TGF-B
stimulated MCF10A(Supplementary Fig. 6a-c). All positive controls exhibited alonger
fluorescence lifetime compared to controls Supplementary Fig. 5a-e, k, 6b, c). Two
negative controls were implemented1) an AKT-specific inhibitor, Honokiol,and 2)a nonphosphorylatable mutant Asor peptide were used(Supplementary Fig. 5 f-j). When
compared to the insulin stimulated cells, negative controlsforAsor demonstrated
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decreased fluorescence lifetime with Honokiol at 2.44 ns and the mutant Asor at 2.33 ns
(Supplementary Fig. 5.f-j, k).A similar approach was executed for Vsor,by using VEGFR-2
agonist, VEGF,as a positive control (Supplementary Fig. 7b, i), andVEGFR specific small
molecule inhibitor, Axitinib, as a negative control (Supplementary Fig. 7c-i).
Real time tracking was performed for each sensor in ECFC, in which either Asor
(Supplementary Fig. 8a, b) or Vsor(Supplementary Fig. 9a, c) were internalized
andexhibitedincreased fluorescence lifetime 20 minutes after stimulation with each
respective kinase activator.In addition to monitoring the temporal dynamic of Vsorsignal,
distinct Vsor spatial profiles indicated its nuclear localization (Fig 1c)after 20 minutes’of
stimulation with 20 ng/mL VEGF. This finding is in concordance with previous findings of
VEGFR-2 nuclear localization upon its phosphorylation16.
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Figure 5.1. Monitoring VEGFR-2 AKT signaling cascade in 2D cell culture. (a) Schematic
diagram depicting working principle of biosensors, peptide sensor will bind to kinase
target, upon phosphorylation phospho-tyrosine will be bound to cellular phosphobinding
domain which increase fluorescence lifetime of the reporter. (b) Fluorescence decay of
Vsor (top) and (Asor) (bottom) shows longer fluorescence decay (red) upon kinase
phosphorylation compare to control (blue). inset: basic structure of sensor consists of
kinase recognition sequences (top: yellow = Vsor,bottom:pink=Asor) and common
delivery sequences (blue).(c) Increasing nuclear localization of Vsor after 20 minutes of
20ng/mL VEGF stimulation in Endothelial Colony Forming cells (ECFC). FLIM images (d)
and quantitative analysis (e)for Vsor and Asor upon 20ng/mL VEGF stimulation in ECFC
shows increase of fluorescence lifetime of both Vsor and Asor during 60 minutes’
observation. FLIM images (f) and quantitative analysis (g) of Vsor Asor upon 10 nM
Axitinib inhibition in ECFC for 60 minutes exhibit initial decrease fluorescence lifetime of
Vsor and Asor , followed by increase fluorescence lifetime of Asor for 50 minutes period
and slight increase of Vsor fluorescence lifetime in the end of 60 minutes observation.
Quantitative analysis was performed for three cellular compartments cell nucleus (nuc),
receptor(rec) and cytoplasm (cyt).
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After validating each sensor performance, we tested multiplex ability of Asor and Vsor in
ECFC cells. We replaced fluorophore reporter of Asor from 5-FAM (Ex/Em 492/518 nm)
into Cy5 (Ex/Em 649/670 nm) thus the emission signals of both Asor and Vsor can be
detected simultaneously by using two separate highly sensitive single photon avalanche
diode (SPAD)detector (Supplementary Fig. 10). After stimulating kinase phosphorylation
for 20 minutes (VEGF for Vsor, Insulin for Asor) in ECFCs, both sensors demonstrated
longer fluorescence decay curves (Fig. 1b). VEGFR-2–AKT signaling cascade was observed
during real time multiplex monitoring of Vsor and Asor(Fig 1d, e, Supplementary Video 1
and 2). Within 20 minutes of VEGF stimulation, Vsor exhibited increased fluorescence
lifetime in all three major cellular compartments; cell receptor (membrane area),
cytoplasm and nucleus (Fig 1d, e, Supplementary Fig. 10).
Subsequently, Asor also exhibited increased fluorescence lifetime indicating the increase
of AKT activity in receptor, cytoplasm and nucleus. Dramatic signal-response event of
VEGF induced VEGFR-2 activityis noted in the nucleus following VEGF induced signal
activation in the receptor and cytoplasm (Supplementary video 1). Similar response signal
wasobserved for Asor, however quantitative analysis (Supplementary Fig. 11)reveals
lower signal amplitude for Asor upon VEGF stimulationcompared to Vsor (Fig. 1e)
Interestingly, longer observation of Vsor and Asor signal within 60 minutes’after VEGF
stimulation exhibited bistabilitysignal behavior of both Vsor and Asor(Fig. 1e)
prominentlyin the nucleus and receptor. Amplification of Vsor signal in nucleus and
receptor were observed starting from40 minutes VEGF stimulation.
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After VEGF stimulation for 60 minutes, Axitinib, a potent VEGFR-2 small molecule inhibitor
was introduced and the signal from both sensors were continuously monitor for another
60 minutes (Fig. 1 f, g). Both Vsor and Asor signals were initially decreased upon Axitinib
administration. However, after 20 minutes, while Vsor signal was remain decreased, Asor
signal was increased. In the end of 60-minute treatment of Axitinib, Asor signal
dramatically increased while Vsor also showed slight increased. We also observed similar
elevated Asor and Vsor signal response with different type of VEGFR small molecule
inhibitor Sunitinib in Sunitinib resistant cell line, 786-R 17(Supplementary Fig.12a, b).These
intriguing results have generated two counterintuitive predictions; 1) VEGF induced
VEGFR-2 –AKT signaling does not only involve signal propagation, originating from VEGFR2 activation to AKTactivation, but also implicate certain feedback mechanism from AKT
that in turn sustain the activity of VEGFR-2, 2) Given the fact that

AKT is a

commonsignaling module thatshared by distinct signaling pathways18, 19and activated by
many extracellular signals 20,21inhibition of VEGFR-2 alone will not sufficient to stop AKT
activation via another route of signaling cascade. The activation of AKT will potentially reactivateVEGFR-2. To test our prediction, we treated ECFC with potent AKT small molecule
inhibitor, Honokiol. We monitored both Vsor and Asor signal for 60 minutes
(Supplementary Fig 13a, b). Asor signal was continuously decreased during 60 minutes.
As expected, Vsor shows oscillation signal but decreasing trend in general. This result
indicated the role of AKT in sustained activity of VEGFR-2.
To further test our predictions, we stimulated ECFC with insulin, an agonist for insulin
receptor signaling pathway, in the VEGF free medium, and observed Asor and Vsor signal
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for 60 minutes (Supplementary Fig 14a, b). Insulin activated pathway shared AKTwith
VEFGR-2 signaling pathway22, 23 as a common downstream in their otherwise distinct
signaling cascade. As expected, Asor signal was increased within 20 minutes of insulin
stimulation (Supplementary Fig. 14a, b). Interestingly, in the absence of VEGF, Vsor signal
was also increased,even though the amplitude of its signal was much lower than Asor.
These observationsrevealedthe activation of AKT via other signaling pathwaypotentially
result in VEGFR-2 activation. Therefore, inhibiting VEGR-2 might not be sufficient to
inhibit its downstream signaling cascade activity.
After using Vsor and Asor to monitor VEGFR-2 –AKT signaling cascade in 2D culture of
ECFC, we translated our study in 3D culture of ECFC. In our tissue like-3D model
(Supplementary Fig. 15a-d, Supplementary video 3), ECFC form a vasculature network
structurein 3D culture started in 24 hours (Fig. 2a). Both sensors were uptaken by the
living cells inside the 3D vasculature structure within 30 minutes of incubation with
sensors (Supplementary Fig. 16a-c, Supplementary Video 4). We applied the same
strategy as in 2D study to monitor VEGFR-2 and AKT signaling cascade by using VEGF
stimulation. Consistent with our 2D results, upon VEGF stimulation both Vsor and Asor
signal were increased (Fig. 2b, e). Different region of vasculature structure exhibited
distinct amplitude of signal response upon VEGF stimulation (Fig. 2b). Higher amplitude
of signal increase was noticed especially during cell-cell coalescence within vessels
structure (Supplementary video 5). In concordance with our observation in 2D culture,
bistability signal behavior is also observed for both sensors, in the cells within 3D vascular
network (Fig. 2e). Notably, subtler bistability signal was observed in 3D system compared
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to the signals in 2D culture. This difference could be an indication for the role of
extracellular matrix cue in VEGFR-2-AKT signaling. As in 2D culture, we also observe
decrease in Vsor signal and an increase of Asor signal with the presence of Axitinib (Fig. 2
c,f) indicating the role of another signaling pathways that by pass the inhibitory effect of
Axitinib in VEGFR-2 –AKT signaling cascade.
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Figure 5.2 (a) 3D vasculature network of ECFC stained with actin(green) and Hoechst(red),
FLIM images (b),(c),(d) and quantitative analysis (e),(f),(g) for Vsor and Asorin 3D
vasculature during 60 minutes’ observation:(b)(e) Vsor and Asor fluorescence lifetime
increase upon 10 ng/mL VEGF stimulation, (c)(f) fluorescence lifetime of Vsor and Asor
decrease within 10 minutes upon 20 nM Axitinib treatment, followed by increase
fluorescence lifetime of Asor for 50 minutes and slight increase of Vsor fluorescence
lifetime in the end of 60 minutes observation, (d)(g) Fluorescence lifetime of both Vsor
and Asor increase with the time of 3D culture and with the increase of vessels structure
diameter.
Monitoring Asor and Vsor signal in different time point of vasculogensis revealed
synergism in Asor and Vsor signal in different time point of vasculogenesis (Fig. 2d).
Increase of both Vsor and Asor signals were observed with the formation of vessels
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structure (Supplementary video 6,7), the increase of vessels diameter and 3D vasculature
ages. (Fig. 2d, f).These observations supported previously reported roles of VEGFR-2 –AKT
signaling in the vasculogenesis8, 24.
After testing performance of Asor and Vsor in 2D and 3D culture system, we then tested
the performance of both sensors in monitoring VEGFR-2 –AKT signaling in-vivo. Zebrafish
was used as in-vivo model for its clarity which facilitate optical imaging. Sensor was rapidly
uptake throughout the vasculature system of anesthetized zebrafish (Fig. 3a,
Supplementary Fig. 17 a-c, Supplementary video 8) via intravenous microinjection
through caudal vein

Biodistribution assay was also carried out in older 7 dpf larvae

25

(Supplementary Fig. 17c, f) and younger embryo as early as 3 hpf Supplementary Fig. 17
a, d). Notably, rapid uptake of sensor was observed within 5 minutes after injection in
both ages range and that sensors did not disrupt embryo development into larvae.
(Supplementary video 9, 10,11,12Supplementary Fig. 18). The choice of 5 dpf larvae was
based on its more developed organ than embryo and its higher durability during
transferring and imaging.
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Figure 5.3 (a) Sensors distribution in live 5dpf zebrafish larvae, FLIM images (d),(e) and
quantitative analysis (b),(c) for Vsor and Asor in vasculature area (white box) of zebrafish
depicted in (a) during 60 minutes’ observation: (b)(d) Vsor and Asor fluorescence lifetime
increase upon 100 ng/mL VEGF stimulation, (c)(e) fluorescence lifetime of Vsor and Asor
decrease within 10 minutes upon 100 nM Axitinib treatment, followed by increase
fluorescence lifetime of Asor for 50 minutes and slight increase of Vsor fluorescence
lifetime in the end of 60 minutes observation.
Consistent with the results in 2D and 3D cultures, Vsor signal within vasculature
area of live zebrafishincrease within 20 minutes of VEGF stimulation (Fig. 3a white box,
3d, 3b, Supplementary Video13,14). Subsequent increasing signal of Vsor followed by
Asor upon stimulation with 100 ng/mL VEGF (Fig. 3b, d) was observed. In concordance
with signal response events in 2D and 3D culture, Vsor’s signal decreased upon treatment
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with 200 nM VEGFR-2 inhibitor, Axitinib during 60 minutes of observation (Fig 3e, white
and blue arrow, Fig. 3c) indicating inhibited activity of VEGFR-2. Signaling cascade
between VEGFR-2 –AKT propagates the decrease of VEGFR-2 activity into lower AKT
activity, marked by lower signal of Asor within 10 minutes of Axitinib treatment.
Interestingly, consistent with our finding in 2D and 3D culture, Asor exhibited increase
signal after 10 minutes of inhibition indicating elevation of AKT activity. Slight increase of
Vsor signal was noted in the end of 60 minutes’ observation (Supplementary Video 15,16),
consistent with our finding in 2D and 3D model. Bistability signal behavior of Vsor and
Asor is also observed in-vivo, indicating the presence of positive feedback26. However,
more oscillation signal pattern from both Asor and Vsor were observed compare to the
signal in 2D and 3D cultures (Fig. 3b, c). This oscillation indicate more intricate insulating
mechanism across different pathway involving VEGFR-2-AKT in-vivo, to maintain
pathways specificity and fidelity 27.
5.5 Conclusions
We have developed an approach to monitor real time kinase signaling in 2D, 3D cultures
and in-vivo. To the best of our knowledge, no other biosensing methodology to monitor
multiplex real-time kinase signaling cascade by measuring individual kinase activity within
live intact cells, 3D culture and in-vivo has been reported before. Our approach provides
spatio temporal dynamic of multiplex kinase activity which allow us to interrogate when
and where signaling event occur. This approach can be translated into more complex
kinase signaling dynamic by expanding the number of kinase sensors and choosing
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fluorophore reporters with different dynamic range of their respected fluorescence
lifetime.
5.6 Supplementary Information

Supplementary Figure 5. 1a HPLC characterization of purified Asor
ARKRERAYSFK(5FAM)HHARKKRRQRRRPQ
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Supplementary Figure 5.1b MALDI-TOF characterization of purified
AsorARKRERAYSFK(5FAM)HHARKKRRQRRRPQ
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Supplementary Figure 5.1c HPLC characterization of Vsor
GRRRAAPEDLYK(5FAM)DFLTGRKKRRQRRRPQ

116

Supplementary Figure 5.1d MALDI –TOF characterization of purified Vsor
GRRRAAPEDLYK(5FAM)DFLTGRKKRRQRRRPQ
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a

b

Supplementary Figure 5.2 Asor and Vsor are rapidly internalized (20 min) by different
cell types. Fluorescence lifetime imagesafter 20 minutes’ incubation period of Asor (a)
and Vsor (b) (20 µM each) in different cell types cultured on 2D glass coverslips at 37oC
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Supplementary Figure 5.3 Two different cellular uptake mechanisms of Asor (a,b) and
Vsor (c) in ECFC. Vsor was rapidly internalized by ECFC at both 4oC (V4) or 37oC (V37)
indicating energy-independent transport of Vsor across the cell membrane (c,d) . Two
different type of Asors, one with a 5-FAM reporter (A) and the other with a CY5 reporter
(AC), was only internalized at 37oC suggesting an energy-dependent uptake mechanism
of Asor regardless of the fluorophore reporter (a,b,d). (d) Quantified average fluorescence
intensity of internalized sensors in ECFC cells revealed; (1) Cellular ASOR fluorescence
intensity at uptake temperature 37oC (A37 and AC37) are significantly higher compare to
cellular ASOR fluorescence intensity at 4oC uptake temperature (A4 and AC4). (2) There is
no significant different between Vsor fluorescence intensity at 37oC uptake (V37)
compare to Vsor intensity at 4oC uptake (V4), (3) There is significant different (P=1x10-10)
of Vsor intensity at 37oC uptake compare to Asor intensity at 4oC uptake.
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Supplementary Figure 5.4 Subcellular localization of AKT and VEFGR-2 in ECFC visualized
by Immunofluorescence. Both VEGFR-2 (a) and AKT (b) are localized in the nucleus, cell
membrane and cytoplasm, consistent with the subcellular localization of Asor and Vsor.
The observation was consistent throughout all samples (n=100).
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Supplementary Figure 5.5 Fluorescence lifetime of Asor depends onAKT
phosphorylation. Positive controls for Asor (b-e) showhigher average florescence lifetime
when compared to control (a, 2.3 ns). (b) 5µM treatment FB-1 (3.3 ns),(c) MCF12 p53 (/-) constitutively active AKT mutant (3.4 ns), (d) 100 ng/mL Insulin (3.1 ns), (e)
phosphorylated Serine Asor (3.5 ns) (f) Negative controls for Asor, mutated nonphosphorylatable Asor (2.4 ns) show decreasing average fluorescence lifetime when
compared to cells stimulated with FB1 (3.3 ns). (f).Honokiol, anAKT inhibitor,
treatmentsdecrease Asor fluorescence lifetime in a dose-dependent manner (g)
50µM(2.85 ns), (h) 75 µM (2.75 ns) (i) 100 µM (2.5 ns) (j) 200 µM (2.4 ns).(k) Average
fluorescence lifetime for different treatments (n=100)
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Supplementary Figure 5.6 Fluorescence lifetime shifts of Asor depends onAKT
phosphorylation. Stimulating cells withTGF-β increased Asor fluorescence lifetime in
MCF12A. (a) Schematic depicting cell morphogenesis during 7-day TGF-βtreatment. TGFβ activates AKT and can drive cell morphogenesis towards mesenchymal phenotype
changes. (b) Quantitative analysis reveals increased Asor average fluorescence lifetime at
later time points, (3 days=3.2 ns, 7days=3.4 ns)when compared to baseline condition, cells
at initial treatment with epithelial phenotype (0 days, no TGF-B, 2.5 ns).Engineered
mutant cells of MCF12 A p53(-/-) with constitutively active AKT shows increase of Asor
fluorescence lifetime (3.48 ns). Average fluorescence lifetime for different treatments
(n=100)
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Supplementary Figure 5.7 Fluorescence lifetime shifts of Vsor is VEGFR-2
phosphorylation dependent. (a-d,k) Vsor positive controls show increased average
florescence lifetime when compared to control (2.5 ns) (b) 20 ng/mL treatment VEGF (3.3
ns) Treatment with a VEGFR-2 inhibitor, Axitinib, served as the Vsor negative control and
showed decreasing average fluorescence lifetime when compared to stimulated cells with
VEGF (3.3 ns) in dose dependent manner ( c) 1 nM (2.85 ns), (d) 75 µM (2.75 ns) (i) 100
µM (2.5 ns) (j) 200 µM ( 2.4 ns).Average fluorescence lifetime for different treatments
(n=100)
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Supplementary Figure 5.8 ASOR Fluorescence lifetime depends onAKT phosphorylation
in ECFCs. (a) 20-minute time course images show higher average florescence lifetime in
ECFC treated with insulin (bottom) when compared to control (top) (b) Quantitative
analysis confirmed that ECFCs treated with insulin (red line) not only have a higher
average fluorescence than the control, but also experience detectable changes from the
initial Average Fluorescence Lifetime (2.45 ns to 2.9 ns). On the other hand, the control
does not show any noticeable change in average lifetime over the 20-minute time course
(black line). This observation is representative of three technical replicate and three
independent biological replicate.
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Supplementary Figure 5.9 Vsor Fluorescence lifetime depends onAKT phosphorylation
in ECFCs. (a) 20-minute time course images show higher average florescence lifetime in
ECFC treated with VEGF (bottom) when compared to control (top) (b) Quantitative
analysis confirmed that ECFCs treated with VEGF (blue line) not only have a higher
average fluorescence than the control, but also experience detectable changes from the
initial Average Fluorescence Lifetime (2.455 ns to 2.94 ns).
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Supplementary Figure 5.10 Schematic of Time Correlated Single Photon Counting
Fluorescence Lifetime Imaging (TCSPC-FLIM) system (Picoquant, Germany). Photon
excitation was realized by pulsed picosecond diode laser (460 nm and 637 nm; 40 MHz).
The laser was coupled to the main MicroTime 200 Unit.Images were acquired by raster
scanning with XY-Piezo nanopositioning stage (Physik Instrumente, Germany), which
allow X-, Y-, and Z-movement precision with 80 µm range and X,Y,Z resolution less than
10 nm.Laser beam was reflected toward objective using dichroic mirror (1P-dichroic,
Chroma) and then focused into the sample through long working distance objective (50x,
1.2 NA, Olympus). Fluorescence was collected by the same objective and the emission
wavelength was transmitted by dichroic mirror (1-P-dichroic, Chroma). The emitted light
was guided through 50 µm pinhole and directed into two single photon avalanche diode
detectors (SPAD,SPCM-AQR, PerkinElmer Inc.). A 520±60 nm emission filter was placed in
front of SPAD 1 to collect signal from FAM-5 while a 685±50 nm filter was placed in front
of SPAD 2 to collect emission from the Cy5 fluorophore. The emitted photonswerethen
processed by TimeHarp 260 PC-board (Picoquant, Germany) using time correlated single
photon counting method. The photon data was then stored in Time Tagged Time Resolved
(TTTR) mode. The pixel by pixel data was then stored in the CPU and was further fitted
using SymphoTime software
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Supplementary Figure 5.11 Schematic of method to quantify FLIM images. (a) FLIM
images collected with TCSPC was fitted pixel by pixel to obtain lifetime per pixel in cells.
Average lifetime per cell was determined by averaginglifetime of 22,500 pixels (n=100
cells). (b) For subcellular quantification, fluorescence decay curves foreach designated
region of interest was fitted to obtain average lifetime. (c) Example of fitting experimental
decay with a bi-exponential model employing Levenberg-Marquadt algorithm. The fit was
performed such that there was i) sufficient Chi value (<1.3) and ii) no residual pattern (d)
was observed
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Supplementary Figure 5. 12 VEGFR Inhibition (via 24-hour 5µM Sunitinib treatment)
leads to AKT activation in Sunitinib-resistant 786-R cells (a) After treatment,
fluorescencelifetime of both Vsor and Asor increasedin 786-R cells,which was further
pronounced in the nucleus. (b) After treatment,a statistically significant increase (P=2x105) in Vsor fluorescence lifetime was observed (2.88 ns vs 2.48 ns observed in control). A
similar observation was observed for Asor fluorescence lifetime (P= 2x10-6) posttreatment (2.9 ns vs. 2.5 ns for control).
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Supplementary Figure 5.13 Real time monitoring of Asor and Vsor after 1-hour AKT
inhibition (treatment with 100µmHonokiol). (a)Fluorescence lifetime image time-course
of Vsor (top) and Asor (bottom) of shows an overall trend of decreasing fluorescence
lifetime for both sensors, although a noticeable increase in Vsor fluorescence lifetime was
noted at 20 minutes. (b) Quantitative analysis show a larger decrease in Asor fluorescence
lifetime after Honokiol treatment, which is followed byrelatively smaller decrease in Vsor
fluorescence lifetime. Vsor shows oscillating response starting from 20 minutes with
general decreasing trend. Data representative of three independent biological replicate
and three technical replicates.
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Supplementary Figure 5.14 Real time monitoring of Asor and Vsor after 1-hour AKT
stimulation (treatment with 100 ng/mL insulin). (a)Fluorescence lifetime time-course of
Vsor (top) and Asor (bottom) showed an initial increase for the first 20 minutes, followed
by an oscillatory behavior for the remaining time period. (b) The results drawn from the
qualitative images were validating by quantifying the relative change to fluorescence
lifetime in both sensors. In the first 20 minutes, both sensors increased, however Asor
(red line) increasing to a greater extent than Vsor (blue line). After 20 minutes, both
sensors exhibited a decreasing oscillatory response. Data representative of three
independent biological replicate and three technical replicates.
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Supplementary Figure 5. 15 Tissue like 3D vasculature of ECFC. (a) Tissue-like 3D culture
of ECFC in type I collagen oligomers in medium (b)10x objectivemicrovessel network
within tissue-embedded ECFC-oligomer sphere tissue after 3 days of culture
stainedwithPhalloidin(green) and Hoechst (red) for visualization of F-actin and nucleus,
respectively. (c) 20x objective (d) 60 x objective

Supplementary Figure 5. 16 ECFCs cultured using multitissue interface method
successfully uptake Asor and Vsor after 30 minutes of incubation with 15 µM of each
sensor(a) 10x magnification images of embedded-oligomer sphere cultures via (a)bright
field(b) Asor fluorescence intensity and (c) Vsor fluorescence intensity
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Supplementary Figure 5.17 Biodistribution of Asor (bottom-red) and Vsor (top-green)
10 minutes after sensor was microinjectedinto zebrafish at different ages of
zebrafish(a,d) 3-hours post fertilization (3hpf) embryo (b,e) five days post fertilization
(5dpf) (c,f) seven days post fertilization (7dpf)
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a

b

c

Supplementary Figure 5.18 Qualitative evaluation of zebrafish development after
biosensor uptake. Biosensor was microinjected into (a) 3hpf embryo and returned into
culture (Egg water, 27°C). Embryo was then imaged at (b) 48 hpf and (c) 7 dpf. All returned
embryos (n=5) successfully developed into larvae and no changes in phenotype were
observed when compared to control
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CHAPTER 6 VISUALIZING ACETYLATION: REAL-TIME FLUORESCENCE LIFETIME IMAGING
OF PEPTIDE BIOSENSOR ACETYLATION IN LIVING 2D AND 3D CELLS CULTURE

6.1 Abstract
Acetyltransferase1 is a member of transferase group responsible for transferring acetyl
group from Acetyl-CoA to amino group of a histone lysine residue. P300/CBP associated
factor2, PCAF, is an essential acetyltransferase enzyme in charge of acetylation of histone
and non-histone protein. Acetylation3 itself is a well-characterized post-translational
modification that regulates diverse cellular process, especially transcriptional activity, in
prokaryote and eukaryote. Most study4-6 of protein acetylation activity involve
biochemical method that will not provide information of its spatiotemporal dynamic.
Herein we describe a novel approach to monitor PCAF acetylation activity in living cells
using Time Correlated Single Photon Counting Fluorescence Lifetime Imaging (TCSPCFLIM) of peptide biosensor which enable real-time longitudinal measurement of
acetylation activity with high spatiotemporal resolution in live intact cells within 2D and
3D cultures.
6.2 Introduction

PCAF is tightly regulated histone acetylation enzyme pertinent in diverse cellular
processes such as transcriptional control7. This ubiquitously expressed enzyme holds key
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role in multiple cellular processes owing to its rather distinct spatiotemporal profile8, 9.
Distinct spatial and temporal profiles of PCAF result in different acetylate activity10 which
ultimately modulate diverse cellular response. Several methods11-13 have been reported
to monitor PCAF or other acetyl transferase protein activity.

However, classical

techniques to detect acetyl transferase activity, more specifically PCAF, were generally
limited to biochemical assay in-vitro or immunofluorescence technique in fixed cells. Such
methods pose challenges in interrogating spatial and temporal dynamic aspect of protein
acetylation. Some approaches have used genetically encoded biosensor or FRET based
biosensor14,

15

to monitor real time acetylation activity. These approaches also have

certain drawbacks, such as the uniform and stable transfection for genetically encode
sensor and multiplex ability for FRET based sensor. Here we report a novel approach to
monitor acetylation activity in living cells using peptide biosensor16 and TCSPC-FLIM.
Fluorescence lifetime based reporter is an ideal probes owing to its nanosecond scale
decay which is influenced by its environment. Furthermore, FLIM technique which is not
confounded by photo bleaching or fluctuation in excitation source, hence a robust
method for longitudinal observation, was applied to detect acetylation dependent
fluorophore lifetime shifts (1–2 ns) in intact, living cells within 2D and 3D cultures (Figure
2 and 3).
PCAF primarily acetylates lysine 14 of Histone 317, therefore we hypothesized that
putative histone 3 peptide containing lysine 14 will be recognized by PCAF as their target
substrate (Fig. 1b). PCAF biosensor (HATSOR) was designed based on Histone 3 sequences
(Fig.1b) including amino acids adjacent to lysine 14 (Fig.1b). TAT sequence (light blue) was
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added to putative Histone 3 (Fig. 1b, dark blue) to aid live cell delivery. As a reporter, a
fluorophore, 5-FAM, was conjugated to Lysine amino acids +4 of acetylation site
(Supplementary Fig. 1).
6.3 Materials and Methods
Peptide Biosensor
Peptide sensors were designed based on our previous work. HATSOR contains acetylable
lysine. A delivery sequence was then added to the main kinase-recognition sequence
(Supplementary Fig 1). All peptides were prepared by Alpha Diagnostic with >90 % purity.
Characterization of labeled materials are provided in the Supporting Information.
In-vitro 2D cell culture
LNCaP were grown in RPMI-1640 supplemented with 10% FBS, 1% Penicillin Streptomycin,
2mM L-glutamine, 10mM HEPES and 1mM sodium pyruvate. Cells were passaged at 90%
confluence; passages less than fifteen were used. PC3 were cultured in RPMI-1640
supplemented with 10% FBS and 1% Penicillin/Streptomycin. RPWE-1 was cultured
Keratinocyte Serum Free Medium (K-SFM), (Thermoscientific) Catalog Number 17005-042
supplemented with Epidermal Growth Factor 1-53 (EGF 1-53) and Bovine Pituitary Extract
(BPE). All cell cultures were maintained at 5% CO2 at 37°C. Prior to imaging, cells were
cultured on cover slips (12mm diameter, 1.5 thickness) in 12 well plate for 24 hours,
followed by sensor delivery. For stimulation, cells were starved with serum free medium
for one hour, then stimulated with MS-275 1µM (Selleckchem, Catalogue number S1053)
during FLIM monitoring. For studies involving PCAF inhibition, Anacardic Acid (SCBT) was
added into medium during real time FLIM monitoring.
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In-vitro 3D cell culture
3D culture was performed with embedding cells in collagen matrix. Briefly, cells were
suspended in neutralized collagen at 5×106 cells/mL, subsequently embedded into 48well plates containing neutralized collagen. Embedded cells were then placed into an
incubator (5% CO2; 37°C) to induce collagen matrix polymerization. Afterwards, 500µL
medium was added and replaced daily.
Sensor delivery in 2D and 3D
For sensor delivery in 2D cultures, cells were incubated with a peptide sensor (HATSOR
µM) in the corresponding appropriate culture medium, washed three times with 1× PBS,
and mounted in the imaging chamber. For sensor delivery in 3D cultures, collagen tissues
were incubated with a HATSOR 15 µM for 30 minutes, washed thrice with 1× PBS, then
the appropriate culture medium added before imaging.
2D and 3D imaging
Since imaging was performed in live cells, we employed a temperature controlled
chamber (37°C) (INU) adapted onto the stage of either TCSPC-FLIM (Picoquant) or A1RMP Confocal System (Nikon). Prior to imaging 2D cultures, cells were cultured on glass
coverslips (#1.5) and were transferred to live-cell chamber disk (courtesy of Dr. Paul
Robinson) with fresh medium. Prior to imaging vascular networks in 3D constructs, tissues
were transferred to glass bottom dishes (#1.5; MatTek Corporation) and filled with fresh
medium.
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Confocal Microscopy
Nikon A1R-MP was used to capture conventional confocal images of 2D and 3D cell
cultures. For fluorophore excitation, a 488nm was used. Signal from HATSOR was
collected via two separate photomultiplier tubes (PMTs). PMT corresponded to a unique
detection channels with emission filter bands of 515/30 nm. Image scanning was
conducted in galvano mode using 512 × 512 pixels @ 4 fps. For all images, the pinhole
was set at 1 Airy Unit (a.u.). For 2D Images, a 60× oil objective was used. For 3D imaging,
a combination of 10×, 20× and 60× objectives were used. Confocal image Z-stacks were
acquired to determine spatial distribution of sensor in the 3D vascular culture.

TCSPC-FLIM
To perform FLIM of the peptide biosensors we utilized a Time Correlated Single Photon
Counting Fluorescence Lifetime Imaging (TCSPC-FLIM) system (MicroTime 200, Picoquant,
Germany) that allowed precise time measurements of i) when fluorophores were excited
and ii) when photons first arrived at the detector. Photon excitation was achieved via a
pulsed picosecond diode laser (460 nm and 637 nm; 40 MHz). The laser was coupled to
the main MicroTime 200 Unit as previously described () and is described in Supplementary
Fig 10. Briefly, a dichroic mirror (1P-dichroic, Chroma) was used to reflect a laser beam
through a long working distance objective (50x, 1.45 NA, Olympus) and into the sample.
Images were acquired via raster scanning with XY-Piezo nanopositioning stage (Physik
Instrumente, Germany). Fluorescence was collected by the same objective and emitted
photons were transmitted by a dichroic mirror (1-P-dichroic, Chroma), through a 50-µm
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pinhole, and directed into two single photon avalanche diode detectors (SPAD, SPCMAQR, PerkinElmer Inc.). To collect emitted photons from the FAM-5 fluorescent reporter,
a 520±60 nm filter was placed in front of SPAD . The captured photons were then
processed by TimeHarp 260 PC-board (Picoquant, Germany) using TCSPC and the data
was stored in Time Tagged Time Resolved (TTTR) mode. Data analysis to obtain
fluorescence lifetime was performed with SymPho Time (A Symphony of Photons in Time)
software (Picoquant, Germany).
To obtain pixel-by-pixel average fluorescence lifetime, the experimental fluorescence
decay curve was fitted with a multiexponential model. Specifically, a non-linear least
squares analysis employing iterative Levenberg–Marquardt routine was used to do a
pixel-by-pixel fitting of the experimentally observe fluorescence decay. LevenbergMarquadt was chosen for its computational efficiency (Supplementary Fig 10). The
equation used for this model is:

where I(t) is the fluorescence intensity at time after excitation pulse, and n is the total
number of decay components in the exponential sum. The variables τi and αi are the
fluorescence lifetime and fractional contribution of the i-th emitting species, respectively.
In this work, bi-exponential model was chosen to fit the experimental decay to obtain the
average fluorescence lifetime per pixel. Assessment of fitting was done by minimizing the
Chi-square value. To ensure unbiased fitting, we excluded Chi-square values greater than
1.3. The average fluorescence lifetime was determined in each cell, with a minimum of
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100 cells in each of the groups. For average fluorescence lifetime of subcellular regions,
the subcellular Region of Interest (ROI) was determined using SymphoTime software, it’s
corresponding decay information was extracted and fitted to obtain respective average
fluorescence lifetime of the ROI.
Statistic
For 2D experiments at least 100 cells from 3 different biological replicates was used for
analysis. For 3D experiments, 3 different technical and 3 different biological replicates
was performed. For in-vivo experiments, three biological replicates with n=6 zebrafish
was conducted. To compare means among different groups, an ANOVA was completed
(α=0.05) with a Fisher least significant difference (LSD) post-hoc test to determine groups
that were statistically different from each other.
6.4 Results and Discussion
Based on our previous work in phosphorylation sensor16, the proposed working
principle of HATSOR is: upon acetylation by the target acetyltransferase, the acetyl group
in the sensor will bind to acetyl-binding domain18 which will change the solvatochromic
environment of the sensor reporter, hence change its fluorescence lifetime in a
acetyltransferase dependent manner , (Fig. 1e). To proof our concepts that HATSOR
fluorescence lifetime depends on PCAF acetylation we performed acetylation assay with
HATSOR as a substrate and observed HATSOR fluorescence lifetime in solution over 90
minutes of time. FLIM images (Fig. 1a) demonstrated gradual increase of average
fluorescence lifetime of HATSOR in solution in the presence of PCAF and Acetyl co-A at
assay condition. This result suggest HATSOR fluorescence lifetime depends on PCAF
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acetylation in solution. To validate this observation, we performed quantitative analysis
by comparing fluorescence decay curve of HATSOR at different time points and further
fitted the decay curve with multiexponential model19 to obtain average fluorescence
lifetime at different time points. HATSOR exhibited longer decay curve with increasing
time of acetylation assay (Fig.1c) indicating the sensor’s fluorescence decay depends on
PCAF acetylation (Fig. 1c). Decay fitting validated our finding by demonstrating increase
of average fluorescence lifetime of HATSOR over time from initial time point of
acetylation assay (3.4 ns to 4 ns) (Fig. 1d).
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Figure 6.1. Proof of concepts. (a) Monitoring PCAF acetylation in solutions.
HATSOR fluorescence lifetime is acetylation dependent in solution. Fluorescence lifetime
of HATSOR increase over time from 3.3 ns to 4.1 ns during 90 minutes of acetylation assay.
(b) Cartoon depicting design process of biosensor; Histone 3 (blue) within histone
complex DNA (white) is major substrate for major acetyltransferase enzyme and Lysine14
of H3 is a site for PCAF acetylation (K14) (ref). Adjacent amino acid (+/-4) of K14 were
chosen as the recognition sequence of biosensor (blue). Modified Tat sequences was
added to recognition part to enable live cell imaging. (c) Quantitative analysis of HATSOR
upon addition of PCAF enzyme to HATSOR solution in the presence of Acetyl group donor,
Acetyl-CoA, shows increasing HATSOR fluorescence lifetime during 90 minutes’
acetylation assay. (d) Fluorescence decay of HATSOR shows longer fluorescence decay
over time (t(minutes)= 0(purple), 10(red), 30(blue), 60(orange), 90(green)) upon HATSOR
acetylation. (e) Schematic diagram depicting working principle of biosensors, peptide
sensor will bind to histone acetyltransferase (HAT) target, upon acetylation phospholysine will be bound to bromodomain which increase fluorescence lifetime of the reporter.
(f) Schematic representation of PCAF structure
After validating our concept in solution, we tested our sensor performance in live
2D culture cells. One of the major challenge for genetically encoded or nanoparticlebased sensors is achieving uniform uptake between different cell lines20. The efficacy of
cellular delivery for PCAF sensor was tested in three different cell lines (Supplementary
Fig. 3a-c). Each sensor was rapidly internalized across cellular membrane within 20
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minutes. To validate subcellular localization, three types of cells were stained via
immunofluorescence and visualized with confocal microscopy (Supplementary Fig. 3d-i).
To assess acetylation and PCAF acetyl transferase–dependence of the HATSOR
fluorescence lifetime shifts, positive and negative controls were used. As a positive
control experiment we treated LNCaP cells with MS-275, histone decatylation inhibitor
that has been reported to accumulate acetylated histone 321. FLIM images demonstrate
that positive controls (Fig.2b) exhibited a longer fluorescence lifetime compared to
nontreated controls (Fig. 2a). Small molecule inhibitor for PCAF acetyl transferase activity,
Anacardic Acid (AA)22, was used in negative controls experiments. When compared to the
MS-275 stimulated cells, FLIM images for negative controls for HATSOR demonstrated
decreased fluorescence lifetime with AA at 2.57 ns (Fig. 2.f-j, k). Further treatment with
different dose of AA revealed that HATSOR fluorescence lifetime is decreased in dose
dependent manner (Fig.2c-f). Quantification of average fluorescence lifetime in each
treatment for at least 100 cells validated our observation that HATSOR fluorescence
lifetime change depend on PCAF acetylation. FLIM images of cells at different stages of
mitosis, metaphase (Fig.2g), anaphase (Fig.2h), and cytokinesis (Fig.2i) revealed higher
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activity of PCAF acetylation in the chromatin, which is consistent with reported function
of PCAF in cell mitosis23, 24.

Figure 6.2. Fluorescence lifetime changes of HATSOR depends on PCAF acetylation
in 2D LnCaP cells. Positive controls for HATSOR, 5µM treatment MS-275 (b), shows higher
average florescence lifetime (4.3 ns) when compared to control (a,3.1 ns). (c-f) Anacardic
Acid, an PCAF inhibitor, treatments decrease HATSOR fluorescence lifetime in a dosedependent manner (c) 500 nM (3.8 ns), (d) 1 µM (3.5 ns) (e) 5 µM (3.2 ns) (f) 8 µM (2.8
ns). (n) Average fluorescence lifetime for different treatments (n=100). (g-i) Average
fluorescence lifetime of HATSOR in different stage of cell division. (k-m) 20-minute time
course images show increase of average florescence lifetime of HATSOR in LnCap,
especially in cell nucleus, upon treatment with MS-275 when compared to control (t=0
minutes). (b) Quantitative analysis confirmed that LnCap treated with MS-275 not only
have a higher average fluorescence lifetime than the control (HATSOR in LnCap without
treatment), but also experience detectable changes overtime from the initial (t=0)
average fluorescence lifetime (2.45 ns to 2.9 ns).
After validating HATSOR fluorescence lifetime acetylation dependent in 2D cell
culture, we tested real time performance of HATSOR by stimulating cells with either PCAF
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inhibitor AA or activator MS-275, and recorded its fluorescence lifetime over 25 minutes’
observation. Within 25 minutes of MS-275 stimulation, HATSOR exhibited increased
fluorescence lifetime (Fig.2k-m, Supplementary Fig.4a, b). Dramatic signal-response
event of MS-275 induced PCAF activity is noted in the nucleus following MS-275 induced
signal activation (Supplementary video 1). This observation is consistent with previous
finding which stated cytoplasmic PCAF acetylation will increase its nuclear export13.
Opposite response signal was observed for HATSOR within 25 minutes after treatment
with AA (Supplementary Fig.4c, d).
Quantitative analysis (Fig.2o) confirmed that HATSOR in LNCaP treated with MS275 (orange line) not only have a higher average fluorescence lifetime than the control,
but also experience detectable changes from the initial average fluorescence lifetime (3.1
ns to 3.41 ns). On the other hand, the control does not show any noticeable change in
average lifetime over the 25-minute time course (green line). This observation is
representative of three technical replicate and three independent biological replicate.
In negative control experiment, quantitative analysis also validated real time
response of HATSOR upon inhibitor. Upon AA treatment, HATSOR not only exhibited
lower average fluorescence lifetime compared to control, but also demonstrate
detectable decrease from its initial fluorescence lifetime (Fig.2p).
After validating HATSOR to monitor PCAF acetylation activity in 2D culture of
LNCaP, we translated our study in 3D culture of LNCaP. In our tissue like- 3D model
(Supplementary Fig. 15 a-d, Supplementary video 3) in collagen matrix (Fig.3, LNCaP cells
exhibited transformed phenotype from its spindle like in 2D culture into acinar structure
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in 3D collagen matrix started in 5 days (Fig. 2a). This transformation is consistent with
previous study for prostate cancer 3D model25, 26. To test sensor performance in 3D
system, sensor delivery into tumor like 3D structure of three different cells line, LNCAp,
RWPE and PC3 was performed. HATSOR was uptaken by the living cells inside the 3D
tumor structure within 30 minutes of incubation with sensors (Supplementary Fig. 16 ac, Supplementary Video 4). One criteria for sensor for live cells should be its
biocompatibility27. In order to evaluate HATSOR biocompatibility with live 3D system, we
tested whether the sensor cause considerable stress in 3D cells, by comparing ROS level
and mitochondria health in 3D cells with or without HATSOR. There is no statistical
difference of ROS sensor intensity signal between 3D LNCaP in the presence and absence
of HATSOR.
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Figure 6.3. Fluorescence lifetime changes of HATSOR depends on PCAF acetylation
in 3D LNCaP cells. (a) 2D culture of LNCaP cells stained with F-actin green and Hoechst
shows spindle like phenotype which is different than its acinar phenotype in 3D culture.
(b) 3D culture of LNCaP in collagen matrix for 5 days stained with Hoechst, F-actin green
and Mitotracker red shows acinar structure (c) tissue like 3D collagen gel (d) collagen
matrix (e) HATSOR (green) was uniformly uptaken by live LNCaP in collagen 3D culture (f)
Live LNCaP 3D culture stained with Mitotracker red and HATSOR (green) shows HATSOR
does not disrupt general cell’s health in 3D culture (g) Quantitative analysis of HATSOR
acetylation in 3D culture over 25 minutes shows decrease of HATSOR fluorescence
lifetime in the course of 25 minutes upon cell treatment with Anacardic Acid 5 mM, while
there is not apparent decrease trend in the non-treated cells over the same period of time.
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This results indicate that HATSOR (20µM) does not increase the production of ROS
in live 3D cells, in which such production can subject cells to DNA damage and apoptosis28.
We further tested HATSOR effect on the 3D cells by testing its mitochondrial health with
Mitotracker red-FM29. We observed the same intensity of MitoTracker-FM intensity in 3D
live cells before and after HATSOR uptake (Fig.3f) which indicate HATSOR does not change
mitochondria health.
After testing biocompatibility of HATSOR in 3D cells, we applied similar strategy as
in 2D study to monitor PCAF acetylation by using PCAF inhibition. Consistent with our 2D
results, upon AA treatment, HATSOR signal was decreased (Fig. 3h, i). Quantitative
analysis (Fig. 3g) also validate FLIM images (Fig.3h) that HATSOR average fluorescence
lifetime (orange) was decreased after AA treatment compare to non-treated control
(green). Moreover, HATSOR also demonstrate lower fluorescence lifetime overtime (30
minutes’ period) compare to its initial average fluorescence lifetime. Interestingly,
fluorescence intensity map reveals that nuclear intensity of 3D LNCaP was also decreased
with AA treatment. This finding is consistent with previous study that suggested lower
PCAF acetylation ultimately inhibit its nuclear localization.
PCAF acetylation by using HATSOR also reveal PCAF response toward extracellular
matrix. We measured HATSOR average fluorescence lifetime in 3D LNCaP with two
different collagen matrix stiffness (Supplementary Fig. 6). We observed higher average
fluorescence lifetime of HATSOR in 3D LNCaP in stiffer matric (1000 pa) compared to that
in 200 Pa matrix. This observation suggested that HATSOR is also responsive toward
mechanical stimulation such as extraellular matrix stiffness stiffness.
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6.5 Conclusions
In conclusion, we have developed an approach to monitor real time PCAF acetylation in
2D and 3D cultures and in-vivo. To the best of our knowledge, no other biosensing
methodology to monitor multiplex real-time kinase signaling cascade by measuring
individual kinase activity within live intact cells, 3D culture and in-vivo has been reported
before. Our approach provides spatio temporal dynamic of acetyltransferase activity
which allow us to interrogate when and where acetylation event occur. This approach can
be translated into more complex acetylation signaling dynamic by expanding the number
of acetyltransferase sensors and choosing fluorophore reporters with different dynamic
range of their respected fluorescence lifetime.
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6.6 Supplementary Information

Supplementary Figures 1. MALDI –TOF characterization of purified of HATSOR
GSTGGKAPRKQLATKRKKRRQRRR
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Supplementary Figures 2. HPLC
GSTGGKAPRKQLATKRKKRRQRRR

characterization

of

purified

of

HATSOR
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Supplementary Figures 3| Hatsor is rapidly internalized (15 min) by different cells types
in 2D culture. (a-c) Fluorescence lifetime images after 15 minutes’ incubation period at
37oC of Hatsor (20 µM), in different cell types cultured on 2D glass coverslips demonstrate
nuclear and cytoplasmic subcellular localization of Hatsor.(d)-(i) Subcellular localization
of PCAF in PC3 (d,g), LNCaP(e,h) and RWPE-1(f,i) visualized by Immunofluorescence. In all
three type of cells, PCAF is localized in the nucleus and cytoplasm, consistent with the
subcellular localization of Hatsor (a-c). The observation was consistent throughout all
samples (n=100).
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Supplementary Figures 4| Hatsor Fluorescence lifetime depends on PCAF acetylation
in LNCaP. (a,b) 25-minute time course images show higher average florescence lifetime
(a) and intensity (b) of Hatsor in LNCAP treated with histone deacetylase inhibitor MS275, prominently in the nucleus area. (c,d) 25-minute time course images show lower
average florescence lifetime (c) and intensity (d) of Hatsor in LNCAP treated with PCAF
inhibitor Anacardic Acid .These observations are representative of three technical
replicate and three independent biological replicate
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Supplementary Figures 5| Hatsor is rapidly internalized (30 min) by different cells types
in 3D culture. Consistent with sensor delivery in 2D culture, Hatsor can be easily delivered
to 3D culture system (d-i) of PC3, LNCaP, RWPE-1 by incubating the culture with Hatsor
(20mM) at 37 for 30minutes. (a-c) Confocal images of 2D culture of (a) RWPE-1, (b) LNCaP
and (c) PC3 stained with F-actin green and Hoechst show the different phenotype of three
cells type. (d-e) Confocal images of 3D culture of (d) RWPE-1 (e) LNCaP and (f) PC3 stained
with F-actin green and Hoechst show each cell type transformed phenotype to spherical
acinar type compared to their adherent phenotype in 2D culture system. (g-i)
Fluorescence lifetime images after 15 minutes’ incubation period at 37oC of Hatsor (20
µM each), in different cell types cultured in 3D collagen matrix demonstrate nuclear and
cytoplasmic subcellular localization of Hatsor (n=100).
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Supplementary Figures 6|Hatsor fluorescence lifetime in 3D LNCaP is dependent of PCAF
acetylation and PCAF acetylation is dependent upon extracellular matrix stiffness. (a-b)
Confocal image of 5 days’ 3D culture of LNCaP stained with actin and Hoechst shows
stronger F-acting signal in 1000 Pa collagen matrix compare to 200 Pa (b). Fluorescence
lifetime images of 3D LNCaP in different matrix stiffness shows higher average lifetime of
Hatsor in 1000 Pa (3.6 ns ) compare to 200 Pa (3ns) especially in the nuclear region.
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Supplementary Figures 7|Schematic of Time Correlated Single Photon Counting
Fluorescence Lifetime Imaging (TCSPC-FLIM) system (Picoquant, Germany). Photon
excitation was realized by pulsed picosecond diode laser with operating wavelength 460
nm at 40 MHz repetition rate. The laser was coupled to the main MicroTime 200 Unit.
Laser beam was reflected toward objective using dichroic mirror (1P-dichroic, Chroma)
and then focused into the sample through long working distance objective (50x, 1.2 NA,
Olympus). Images were acquired by raster scanning with XY-Piezo nanopositioning stage
(Physik Instrumente, Germany), which allow x,y, and z movement precision with 80 µM
range and x,y,z resolution less than 10 nm. Fluorescence was collected by the same
objective and the emission wavelength was transmitted by dichroic mirror (1-P-dichroic,
Chroma). The emitted light was guided through 50 µm pinhole and it was directed into
two single photon avalanche diode detectors (SPAD, SPCM-AQR, PerkinElmer Inc.).
520±60 nm emission filter was placed in front of SPAD 1 to collect signal from FAM-5
conjugated to Hatsor. The fluorescence light was then processed by TimeHarp 260 PCboard (Picoquant, Germany) using time correlated single photon counting method. The
photon data was then stored in Time Tagged Time Resolved (TTTR) mode. The pixel by
pixel data was then stored in the CPU and can be further fitted using SymphoTime
software.
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Supplementary Figures 8| Schematic of quantitative analysis of FLIM image. (a) FLIM
images collected with TCSPC was fitted pixel by pixel to obtain lifetime per pixel in cells.
Average lifetime per cell was determined by taking the average of 22.500 pixels’ lifetime
decay information. For quantification purposes ~100 cells was used. c) Example of fitting
between experimental decay with bi-exponential model employing Levenberg-Marquadt
algorithm. The fitting was done until sufficient Chi value (<1.3) was achieved and no
residual pattern (d) was observed
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CHAPTER 7 TWO PHOTON FLUROESCENCE LIFETIME IMAGING TO ASSES
PERFLUORONATED COMPOUND EFFECT ON HEPATOCYTE CELLULAR METABOLISM

7.1 Abstract
Perfluorooctanoic acid (PFOA), an eight-carbon chain perfluorinated carboxylic acid, was
used heavily for the production of fluoropolymers, but concerns have led to its
replacement by shorter carbon chain homologues such as perfluorohexanoic acid (PFHxA)
and perfluorobutanoic acid (PFBA). However, limited toxicity data exist for these
substitutes. We evaluated the toxicity of PFOA, PFHxA, and PFBA on a zebrafish liver cell
line (ZFL) and investigated the effects of exposure on cell metabolism. Gross toxicity after
96 h of exposure was highest for PFOA and PFO-, while PFHxA and PFBA exhibited lower
toxicity. Although the structural similarity of these compounds to fatty acids suggests the
possibility of interference with the transport and metabolism of lipids, we could not
detect any differential expression of ppar-α,β,γ, fabp3 and crot genes after 96 h exposure
to up to 10 ppm of the test compounds. However, we observed localized lipid droplet
accumulation only in PFBA exposed cells. To study the effects of these compounds on cell
metabolism, we conducted Fluorescence Lifetime Imaging Microscopy using naturally
fluorescent biomarkers NADH and FAD. The fluorescence lifetimes of NADH and FAD and
the bound/free ratio of each of these coenzymes decreased in a dose- and carbon lengthdependent manner suggesting disruption of cell metabolism. In sum, our in vitro study
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using ZFL cells revealed that PFASs with shorter carbon chains are less toxic than PFOA,
and that exposure to PFOA, PFHxA or PFBA affects cell metabolism. Therefore, the
application of shorter-chain alternatives is not without risk.
7.2 Introduction
Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are synthetic chemicals that
are very stable compounds due to their strong carbon-fluorine bonds 1. They are highly
persistent organic pollutants2, 3 and are widely used in industry as well as consumer
products. The eight-carbon perfluorooctanoic acid (PFOA) is the best-studied member of
a subclass of PFASs called perfluorinated carboxylic acids. PFOA is one of the most
commonly detected PFASs in the environment and it exhibits a high bioaccumulation
potential4-6.
In an effort to study the toxicity and effects of PFOA as well as the shorter chain
homologues PFHxA and PFBA on cellular metabolism, we carried out in vitro experiments
using ZFL cells, a permanent cell line originating from the zebrafish (Danio rerio) liver7. In
vitro models are cost effective and allow the testing to be done in a more controlled way
to reduce the inter-individual and inter-experimental variations that often occur in vivo 8.
Our objective was to compare the gross toxic effects of PFOA, PFHxA, and PFBA and then
to investigate the effect of each of these chemicals on cellular metabolism. We used the
intrinsic fluorescent biomarkers NADH and FAD to investigate the effect of the PFASs on
cellular metabolism. We hypothesize that the toxic effect of the test compounds will be
proportional to the dose and carbon chain length. The outcome of our experiments will
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provide data for risk management and will help to explore the effects of shorter chain
PFASs.
7.3 Materials and Methods
7.3.1 Chemicals and test solutions:
The perfluorinated carboxylic acids perfluorooctanoic acid (PFOA, CAS № 335-67-1),
perfluorohexanoic acid (PFHxA, CAS № 307-24-4), and perfluorobutanoic acid (PFBA, CAS
№ 375-22-4) of >96% purity used in the experiments were purchased from Sigma-Aldrich
Corporation (St. Louis, Missouri, USA). For the in vitro exposure of zebrafish hepatocytes,
each of these compounds was dissolved in dimethylsulfoxide [DMSO] (Cat № D8418,
Sigma) to obtain a 1M stock solution and the final concentration of DMSO in vehicle
controls and treatments was ≤ 0.2% DMSO.
7.3.2 Cell Culture:
Zebrafish liver cell cultures, ZFL cells [ZF-L] (ATCC® CRL2643™) were obtained from the
American Type Culture Collection (Manassas, Virginia, USA). Cells were routinely
maintained in an atmosphere of humidified air at 28 °C in the culture medium
recommended by the supplier, namely 50% Leibovitz's L15 (ATCC 302008), 35%
Dulbecco's Modified Eagle's Medium HG (GIBCO 12100), 15% Ham's F12 (GIBCO 21700),
0.15 g/L sodium bicarbonate, 15 mM HEPES (J.T. Baker Chemical 4018-01) pH 7.6, 0.01
mg/ml bovine insulin (Sigma-Aldrich 10516), 50 ng/ml mouse EGF (Sigma-Aldrich
SRP3196), 5% fetal bovine serum (Life Technologies 10437-028), 100 units/mL penicillin
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and 100 µg/mL streptomycin (JR Scientific 20001). For statistical purposes, separate
passages of cell cultures in separate culture plates were considered independent units.
7.3.3 Imaging by Fluorescence Lifetime Imaging Microscopy: Fluorescence Lifetime
Imaging Microscopy (FLIM) is a preferred non-invasive imaging technique to visualize
alterations in metabolic state by tracking naturally fluorescent intracellular coenzymes
such as nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD).
Fluorescence intensity as well as fluorescence lifetimes of NADH and FAD can be
measured by FLIM to indicate the metabolic state of cells or tissue in biological samples
. We imaged control as well as 24 h-exposed ZFL cells to study the effect of these

9

chemicals on cell metabolism using autofluorescent NADH and FAD as biomarkers.
Cells were seeded onto 18 mm glass coverslips (Neuvitro, Germany) in 12-well plates and
cultured as described above until ~ 60–70% confluent. Each well was exposed to different
concentrations of PFOA, PFHxA and PFBA (0, 0.5, 5 or 10 ppm) for 24 h in a complete
factorial design. A shorter 24 h exposure was preferred for a better quality image. The
following procedure was conducted before repeating the entire experiment twice more
on two separate days, resulting in a randomized complete block design in which separate
days functioned as blocks. Coverslips were mounted to the imaging chamber and
maintained with cell medium during imaging. Approximately 100 cells were imaged using
a 2 Photon Time Correlated Single Photon Counting Fluorescence Lifetime Imaging (2P
TCSPC-FLIM) system. Two photon excitation was executed using a mode-locked
Ti:Sapphire Chameleon™ Ultra femtosecond laser system (Coherent, Inc., Auburn, CA)
operated at a wavelength of 760 nm and 80 MHz repetition rate. The near-infrared laser

166
was directed through a circular neutral density filter to adjust its average power and
subsequently coupled to the main MicroTime 200 Unit. Details of the instrumentation
have been described previously

10, 11

. Briefly, the laser beam was guided towards the

objective using a dichroic mirror (2P-dichroic, Chroma) and then focused into the sample
through an apochromatic water immersion objective (60x, 1.45 NA, Olympus). Images
were acquired by raster scanning with a xy-piezo stage (Physik Instrumente, Germany).
Fluorescence was collected by the same objective and the emission wavelength was
separated from excitation wavelength by another dichroic mirror (2P-dichroic, Chroma).
The emitted light was guided through a 100µm pinhole and was split into two single
photon avalanche diode detectors (SPAD). A 460 ± 25 nm emission filter (Omega Optical,
Brattleboro, VT) was placed in front of SPAD 1 to collect NADH signal and a 520 ± 60 nm
emission filter in front of SPAD 2 to collect FAD signal. The signals were then processed
using TimeHarp 200 PC-board (PicoQuant, Germany) for time-correlated single photon
counting. The photon data were then stored in time tagged time resolved mode. Data
analysis to obtain fluorescence lifetime was performed with software PicoQuant. In order
to determine average fluorescence lifetime, as well as the population of bound (a1) and
unbound (a2) NADH and FAD, fluorescence decay curves for each image were estimated
as described in our previous work. Fluorescence decay tail fitting was estimated with
multiexponential fit by employing Levenberg-Marquadt minimization algorithm
until no residual pattern is observed. A minimum of 10 images of 150 x 150 pixels were
taken from each cover slip to observe 25 cells per cover slip. This was repeated with a
total of three independent cultures on separate days.
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7.4 Results and Discussion
PFASs have also been reported to affect cell metabolism 12, 13. To investigate metabolic
changes upon PFOA, PFHxA and PFBA exposures, control and treated ZFL cells were
subjected to live-cell microscopy by 2 photon fluorescence lifetime imaging (2PFLIM)
using naturally fluorescent intracellular NADH and FAD as biomarkers. The average
lifetime of NADH and FAD was calculated using decay fitting following the LevenbergMarquadt algorithm as described above. Differences in fluorescence lifetimes of NADH or
FAD among different cells were apparent in visual reconstructions of 2P-FLIM data (Fig. 1
A, B). The average fluorescence lifetimes of NADH and FAD decreased as the
concentration of the PFAS increased (Fig. 1 C,D). The ratios of bound to free NADH and
bound to free FAD also decreased as the concentration of the PFAS increased (Fig. 2 A, B).
For all of the response variables, the effect was strongest for PFOA, weaker for PFHxA,
and weaker still for PFBA.
Table 1 demonstrate the average fluorescence lifetime of NADH, the average
fluorescence lifetime of FAD, the ratio of bound to free NADH, and the ratio of bound to
free FAD. The average fluorescence lifetimes of bound NADH, free NADH, bound FAD, and
free FAD are given in Table 2.
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Table 7.1: Results (F statistic, p-value) of statistical analysis predicting the responses of
NADH and FAD metabolism within ZFL cells exposured to different chemicals and different
concentrations for 24 h.
Response

Independent variable(degrees of freedom)

variable

Chemical(2,69

Concentration(3,69

Chemical×Concentration(6,69

Replicate(2,69

)

)

)

)

6446, <0.0001

225, <0.0001

0.05, >0.9

948, <0.0001

11.9, <0.0010

0.7, >0.5

8848, <0.0001

598, <0.0001

0.4, >0.6

34361, <0.0001

2293, <0.0001

1.9, >0.2

NADH
average
lifetime

1523,
<0.0001

FAD average

24.4,

lifetime

<0.0010

NADH
bound/free
ratio (α1/α2)
FAD
bound/free
ratio (α1/α2)

3974,
<0.0001

8057,
<0.0001
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Table 7.2: Average fluorescence lifetime of free and bound NADH, and free and bound
FAD in cells exposed to different concentrations of PFBA, PFHxA and PFOA, n=5 cell
populations.
Fluorescence

Fluorescence

lifetime of free lifetime

Fluorescence

Fluorescence

of lifetime of free lifetime of bound

NADH (ns)

bound NADH

FAD (ns)

FAD (n

Control

0.80

4.48

2.56

0.65

0.5 ppm

0.83

4.00

2.48

0.62

5 ppm

0.87

3.80

2.40

0.59

10 ppm

0.88

3.77

2.37

0.43

Control

0.83

4.40

2.55

0.64

0.5 ppm

0.82

3.64

2.45

0.46

5 ppm

0.75

3.50

2.35

0.40

10 ppm

0.74

3.31

2.20

0.38

Control

0.82

4.41

2.56

0.65

0.5 ppm

0.72

2.92

1.60

0.40

5 ppm

0.70

2.85

1.50

0.30

10 ppm

0.68

2.70

1.45

0.25

PFBA

PFHxA

PFOA
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Figure 7.1. NADH (A) and FAD (B) fluorescence lifetimes in ZFL cells after 24 h exposure
to PFOA, PFHxA, or PFBA. Scale bars in panels (Aa) and (Bm) represent 50 µm. Average
fluorescence lifetime of NADH (C) and FAD (D) in ZFL cells decreased with increasing dose
of PFOA, PFHxA, or PFBA.
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Figure 7.2. The bound/free (α1/α2) ratios of NADH (A) and FAD (B) in ZFL cells decreased
with increasing dose of PFOA, PFHxA, or PFBA.All values are presented as mean ± sample
standard deviation; n=3 replicates with 25 observations each. Based on an F test,
estimated p-values were < 0.001 for all three factors influencing the above response
variables (Table S1).
PFASs have been reported to affect cell metabolism 12-14 We investigated the effects of
PFOA, PFHxA and PFBA exposures on metabolism at the single cell level by using two
photon fluorescence lifetime imaging (2P-FLIM). 2P-FLIM represents a non-invasive
imaging technique to visualize alterations in the metabolic state of the cell by tracking
intrinsic fluorophores present in living cells, such as NADH and FAD 15, 16. Both of these
coenzymes play a major role in ATP (adenosine triphosphate) generation via cellular
respiration. These coenzymes are naturally fluorescent, where as their respective redox
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partners, NAD+ and FADH2, are not. NADH is a critical electron donor during oxidative
phosphorylation, the process by which the cell generates most of its ATP. The coenzyme
FAD is associated with mitochondrial respiration, during which it is changed to the highenergy FADH2 form in the tricarboxylic acid cycle and then oxidized once again to FAD in
the electron transport chain, which produces the cellular energy carrier ATP. Thus NADH
and FAD binding can be directly associated with ATP synthesis and the metabolic activity
of a cell. The free and bound states of NADH and FAD have well separated values of
fluorescence lifetimes17. Specifically, a decrease in the fluorescence lifetime of the bound
NADH pool can indicate a change in the cellular energy production pathways from
oxidative phosphorylation toward increased reliance on glycolysis16, 18. Generally, the
fluorescence lifetime of FAD changes from around 2.5 ns in the free form to less than 1
ns when bound to a protein19. For NADH, the fluorescence lifetime changes from around
0.3-0.7 ns in the free form to 2-3 ns when bound to a protein 20.
Our results show that the average as well as the free and protein-bound fluorescence
lifetimes of both NADH and FAD decreased significantly after 24 h exposure to PFOA,
PFHxA, or PFBA. This effect was strongest for PFOA, followed by PFHxA, and PFBA. In all
the treated cells, the relative amount of protein-bound (α1) versus free (α2) NADH and
FAD decreased. A decrease in α1/α2 in NADH and FAD suggests lower metabolic activity
in the PFAS-exposed cells. Previous studies have also shown that a decrease in
fluorescence lifetime and a decrease in the relative contribution of protein-bound versus
free NADH may indicate hypoxic conditions in cells (Schneckenburger et al., 2004). The
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concurrent decrease we observed in the fluorescence lifetimes of bound FAD and free
FAD is consistent with an intracellular shift toward a higher ratio of FADH2 to FAD. The
same pattern was evident with NADH, except that treatment with PFBA caused a
decrease in the fluorescence lifetime of bound NADH and a small increase in the
fluorescence lifetime of free NADH, suggesting that less NADH was being bound by NADH
dehydrogenase.

7.5 Conclusions
FLIM measurement revealed that all three chemicals perturb cell metabolism, as shown
by a decrease in the NADH and FAD fluorescence lifetimes as well as the bound to
unbound ratio (α1/α2) of these two coenzymes. To the best of our knowledge, this is the
first application of FLIM to a toxicological study of PFASs at the cellular level. Although
concerns about the toxicity of PFOA have led to the replacement of this compound with
shorter chain homologues like PFHxA and PFBA in industrial applications, our data reveal
sublethal effects at concentrations as low as 0.5 ppm. Therefore, the switch to shorterchain alternatives is not without risk.
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